tag:blogger.com,1999:blog-57640900549098582732024-02-07T06:49:15.890+01:00Medicines Shortages in EuropeeCOST Action CA15105Medicines Shortages in Europehttp://www.blogger.com/profile/07362716140541888698noreply@blogger.comBlogger7125tag:blogger.com,1999:blog-5764090054909858273.post-25913141576376984162018-01-20T11:32:00.002+01:002018-11-13T11:59:49.992+01:00eCOST Action CA15105<div dir="ltr" style="text-align: left;" trbidi="on">
<div class="separator" style="background-color: #fefdfa; clear: both; color: #5d5d5d; font-family: Arial, Tahoma, Helvetica, FreeSans, sans-serif; font-size: 13.2px; text-align: center;">
</div>
<div class="separator" style="clear: both; text-align: center;">
<a href="http://www.cost.eu/" imageanchor="1" style="clear: left; float: left; margin-bottom: 1em; margin-right: 1em;" target="_blank"><img border="0" data-original-height="119" data-original-width="422" height="55" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEirt4cacTAXLDlZ3V_dw8vlxBhhKdGZhEO7_gRHyxQ6B7KaerLJcSKual4abmU04VS9GafAOVCWor8rOygOK1hrdqZ1iTTEoXIic-Tdqw7xQ7KkQfSlg2CQy_UxYCgmhv8LgOvjaLKvQeB8/s200/eCost+logo.jpg" width="200" /></a></div>
<b style="background-color: #fefdfa; color: #5d5d5d; font-family: arial, tahoma, helvetica, freesans, sans-serif; font-size: 13.2px;"><a href="http://www.cost.eu/" style="color: #3d85c6; text-decoration-line: none;" target="_blank">eCOST</a></b><span style="background-color: white; color: #5d5d5d; font-family: "arial" , "tahoma" , "helvetica" , "freesans" , sans-serif; font-size: 13.2px;"> (</span><b style="background-color: #fefdfa; color: #5d5d5d; font-family: arial, tahoma, helvetica, freesans, sans-serif; font-size: 13.2px;">European Cooperation in Science and Technology</b><span style="background-color: white; color: #5d5d5d; font-family: "arial" , "tahoma" , "helvetica" , "freesans" , sans-serif; font-size: 13.2px;">) is the longest-running European framework supporting trans-national cooperation among researchers, engineers and scholars across Europe.</span><br />
<br style="background-color: #fefdfa; color: #5d5d5d; font-family: arial, tahoma, helvetica, freesans, sans-serif; font-size: 13.2px;" />
<b style="background-color: #fefdfa; color: #5d5d5d; font-family: arial, tahoma, helvetica, freesans, sans-serif; font-size: 13.2px;"><br /></b>
<b style="background-color: #fefdfa; color: #5d5d5d; font-family: arial, tahoma, helvetica, freesans, sans-serif; font-size: 13.2px;">European Medicines Shortages Research Network - addressing supply problems to patients (Medicines Shortages) </b><br />
<br style="background-color: #fefdfa; color: #5d5d5d; font-family: arial, tahoma, helvetica, freesans, sans-serif; font-size: 13.2px;" />
<span style="background-color: white; color: #5d5d5d; font-family: "arial" , "tahoma" , "helvetica" , "freesans" , sans-serif; font-size: 13.2px;">The problems created by supply shortages of medicines have been widely reported by healthcare professionals and patients over recent years, and acknowledged at the European level by the European Medicines Agency and European Commission. The cited causes are multifaceted ranging from production disruptions, natural disasters, discontinuations as well as difficulties created by various legal, trade and pricing frameworks. Healthcare professionals require access to reliable and up-to-date information about the unavailability of a medicine in order that they can treat the patient in the best way possible. The significant patient impact because of the lack of medication, in terms of safety and management of their condition, will be researched. In addition the forced substitution to an alternative product or requirement to produce a medicine may increase the risk of error, stress and overall cost to the healthcare system. According to the largest pan-European survey of healthcare professionals yet conducted on the topic, the products mainly affected in the European hospital sector are antimicrobials and oncology products used for large populations. This Action will encourage systematic sharing of information and research about past, ongoing and future shortages of medicines and nutritional products. The Action aims to respond to clinical, financial and quality of life interests, to achieve analytical clarity on disruption causes, to simulate decision making in medicines production and trade, to highlight restrictive legal and economic frameworks, to disclose disincentives in the supply chain such as conflicts of interest or problematic cost-benefit ratios, and to reflect on best coping practices. </span><br />
<br style="background-color: #fefdfa; color: #333333; font-family: Arial, Tahoma, Helvetica, FreeSans, sans-serif; font-size: 13px;" />
<span style="background-color: white; color: #5d5d5d; font-family: "arial" , "tahoma" , "helvetica" , "freesans" , sans-serif; font-size: 13.2px;">It is a unique means for them to jointly develop their own ideas and new initiatives across all fields in science and technology, including social sciences and humanities, through pan-European networking of nationally funded research activities. Based on a European intergovernmental framework for cooperation in science and technology, COST has been contributing - since its creation in 1971 - to closing the gap between science, policy makers and society throughout Europe and beyond. As a precursor of advanced multidisciplinary research, COST plays a very important role in building a </span><b style="background-color: #fefdfa; color: #5d5d5d; font-family: arial, tahoma, helvetica, freesans, sans-serif; font-size: 13.2px;"><a href="http://ec.europa.eu/research/era/index_en.html" style="color: #3d85c6; text-decoration-line: none;" target="_blank">European Research Area </a></b><span style="background-color: white; color: #5d5d5d; font-family: "arial" , "tahoma" , "helvetica" , "freesans" , sans-serif; font-size: 13.2px;">(ERA).</span><br />
<br style="background-color: #fefdfa; color: #5d5d5d; font-family: arial, tahoma, helvetica, freesans, sans-serif; font-size: 13.2px;" />
<span style="background-color: white; color: #5d5d5d; font-family: "arial" , "tahoma" , "helvetica" , "freesans" , sans-serif; font-size: 13.2px;">It anticipates and complements the activities of the EU Framework Programmes, constituting a “bridge” towards the scientific communities of COST Inclusiveness Target Countries. It also increases the mobility of researchers across Europe and fosters the establishment of scientific excellence.The problems created by supply</span><b style="background-color: #fefdfa; color: #5d5d5d; font-family: arial, tahoma, helvetica, freesans, sans-serif; font-size: 13.2px;"> shortages of medicines</b><span style="background-color: white; color: #5d5d5d; font-family: "arial" , "tahoma" , "helvetica" , "freesans" , sans-serif; font-size: 13.2px;"> have been widely reported by healthcare professionals and patients over recent years, and acknowledged at the European level by the European Medicines Agency and European Commission. The cited causes are </span><b style="background-color: #fefdfa; color: #5d5d5d; font-family: arial, tahoma, helvetica, freesans, sans-serif; font-size: 13.2px;">multifaceted ranging from production disruptions, natural disasters, discontinuations</b><span style="background-color: white; color: #5d5d5d; font-family: "arial" , "tahoma" , "helvetica" , "freesans" , sans-serif; font-size: 13.2px;"> as well as difficulties created by various legal, trade and pricing frameworks.</span><br />
<br style="background-color: #fefdfa; color: #5d5d5d; font-family: arial, tahoma, helvetica, freesans, sans-serif; font-size: 13.2px;" />
<b style="background-color: #fefdfa; color: #5d5d5d; font-family: arial, tahoma, helvetica, freesans, sans-serif; font-size: 13.2px;">Healthcare professionals</b><span style="background-color: white; color: #5d5d5d; font-family: "arial" , "tahoma" , "helvetica" , "freesans" , sans-serif; font-size: 13.2px;"> require access to reliable and up-to-date information about the unavailability of a medicine in order that they can treat the patient in the best way possible. The </span><b style="background-color: #fefdfa; color: #5d5d5d; font-family: arial, tahoma, helvetica, freesans, sans-serif; font-size: 13.2px;">significant patient impact</b><span style="background-color: white; color: #5d5d5d; font-family: "arial" , "tahoma" , "helvetica" , "freesans" , sans-serif; font-size: 13.2px;"> because of the lack of medication, in terms of safety and management of their condition, will be researched. In addition the forced </span><b style="background-color: #fefdfa; color: #5d5d5d; font-family: arial, tahoma, helvetica, freesans, sans-serif; font-size: 13.2px;">substitution to an alternative product or requirement to produce a medicine </b><span style="background-color: white; color: #5d5d5d; font-family: "arial" , "tahoma" , "helvetica" , "freesans" , sans-serif; font-size: 13.2px;">may increase the </span><b style="background-color: #fefdfa; color: #5d5d5d; font-family: arial, tahoma, helvetica, freesans, sans-serif; font-size: 13.2px;">risk of error, stress and overall cost to the healthcare system</b><span style="background-color: white; color: #5d5d5d; font-family: "arial" , "tahoma" , "helvetica" , "freesans" , sans-serif; font-size: 13.2px;">. According to the largest pan-European survey of healthcare professionals yet conducted on the topic, </span><b style="background-color: #fefdfa; color: #5d5d5d; font-family: arial, tahoma, helvetica, freesans, sans-serif; font-size: 13.2px;">the products mainly affected in the European hospital sector are antimicrobials and oncology products</b><span style="background-color: white; color: #5d5d5d; font-family: "arial" , "tahoma" , "helvetica" , "freesans" , sans-serif; font-size: 13.2px;"> used for large populations.</span><br />
<br style="background-color: #fefdfa; color: #5d5d5d; font-family: arial, tahoma, helvetica, freesans, sans-serif; font-size: 13.2px;" />
<br style="background-color: #fefdfa; color: #5d5d5d; font-family: arial, tahoma, helvetica, freesans, sans-serif; font-size: 13.2px;" />
<span style="background-color: white; color: #5d5d5d; font-family: "arial" , "tahoma" , "helvetica" , "freesans" , sans-serif; font-size: 13.2px;">This Action will encourage </span><b style="background-color: #fefdfa; color: #5d5d5d; font-family: arial, tahoma, helvetica, freesans, sans-serif; font-size: 13.2px;">systematic sharing of information and research about past, ongoing and future shortages of medicines and nutritional product</b><span style="background-color: white; color: #5d5d5d; font-family: "arial" , "tahoma" , "helvetica" , "freesans" , sans-serif; font-size: 13.2px;">s. The Action aims to respond to clinical, financial and quality of life interests, to achieve analytical clarity on disruption causes, to simulate decision making in medicines production and trade, to highlight restrictive legal and economic frameworks, to disclose disincentives in the supply chain such as conflicts of interest or problematic cost-benefit ratios, and to reflect on best coping practices.</span><br />
<span style="background-color: white; color: #5d5d5d; font-family: "arial" , "tahoma" , "helvetica" , "freesans" , sans-serif; font-size: 13.2px;"><br /></span>
<br />
<b style="background-color: #fefdfa; color: #5d5d5d;"><span style="font-family: inherit;">Related links</span></b><br />
<span style="font-size: xx-small;"><br /></span>
<br />
<div style="text-align: left;">
<span style="background-color: white; background-position: 0px 0px; background-repeat: no-repeat; color: #bd7e00; font-family: "arial" , "helvetica" , "verdana" , sans-serif; padding-left: 18px;"><a class="linkWithArrowBefore" href="http://www.cost.eu/COST_Actions/ca/CA15105" style="background-color: white; background-position: 0px 0px; background-repeat: no-repeat; color: #bd7e00; font-family: arial, helvetica, verdana, sans-serif; padding-left: 18px;" target="_blank" title="Opens external link in new window">Official Site COST Action CA15105</a></span></div>
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<li style="background-color: #fefdfa; border-bottom-color: rgb(224, 224, 224); border-bottom-style: solid; border-width: 0px 0px 1px; color: #5d5d5d; font-family: arial, tahoma, helvetica, freesans, sans-serif; font-size: 13.2px; line-height: 1.25em; margin: 0px; padding: 0px;"><a class="arrow neues-fenster" href="http://issuu.com/costprogramme/docs/cost_corporate_brochure" style="background-image: url("https://blogger.googleusercontent.com/img/proxy/AVvXsEj8Egaga9_6Q0rXdgohyphenhyphenYzB6-I5PW_2gxCEUP3GPYqD1HUQsskKiULEErhyphenhyphenbHLFOAq9af4ssGcbzHlI1orqxgB7n8mRK2k6FKBygWi7hu9qJbYXWpseUz2_mKL74DOJGxritIKAXGxGr3Mcm5jriAPBVx8rwHPIinj2a04e=s0-d"); background-position: 4px 0.82em; background-repeat: no-repeat; color: #2b6f93; display: block; padding: 0.5em 5px 0.5em 12px; text-decoration-line: none;" target="_blank" title="new browser window"><span style="font-family: inherit;">COST brochure on ISSU</span></a></li>
<li style="background-color: #fefdfa; border-bottom-color: rgb(224, 224, 224); border-bottom-style: solid; border-width: 0px 0px 1px; color: #5d5d5d; font-family: arial, tahoma, helvetica, freesans, sans-serif; font-size: 13.2px; line-height: 1.25em; margin: 0px; padding: 0px;"><a class="arrow neues-fenster" href="http://ec.europa.eu/programmes/horizon2020/en" style="background-image: url("https://blogger.googleusercontent.com/img/proxy/AVvXsEj8Egaga9_6Q0rXdgohyphenhyphenYzB6-I5PW_2gxCEUP3GPYqD1HUQsskKiULEErhyphenhyphenbHLFOAq9af4ssGcbzHlI1orqxgB7n8mRK2k6FKBygWi7hu9qJbYXWpseUz2_mKL74DOJGxritIKAXGxGr3Mcm5jriAPBVx8rwHPIinj2a04e=s0-d"); background-position: 4px 0.82em; background-repeat: no-repeat; color: #2b6f93; display: block; padding: 0.5em 5px 0.5em 12px; text-decoration-line: none;" target="_blank" title="new browser window"><span style="font-family: inherit;">Horizon 2020</span></a></li>
<li style="background-color: #fefdfa; border-bottom-color: rgb(224, 224, 224); border-bottom-style: solid; border-width: 0px 0px 1px; color: #5d5d5d; font-family: arial, tahoma, helvetica, freesans, sans-serif; font-size: 13.2px; line-height: 1.25em; margin: 0px; padding: 0px;"><a class="arrow neues-fenster" href="http://ec.europa.eu/programmes/horizon2020/en/h2020-section/future-and-emerging-technologies" style="background-image: url("https://blogger.googleusercontent.com/img/proxy/AVvXsEj8Egaga9_6Q0rXdgohyphenhyphenYzB6-I5PW_2gxCEUP3GPYqD1HUQsskKiULEErhyphenhyphenbHLFOAq9af4ssGcbzHlI1orqxgB7n8mRK2k6FKBygWi7hu9qJbYXWpseUz2_mKL74DOJGxritIKAXGxGr3Mcm5jriAPBVx8rwHPIinj2a04e=s0-d"); background-position: 4px 0.82em; background-repeat: no-repeat; color: #2b6f93; display: block; padding: 0.5em 5px 0.5em 12px; text-decoration-line: none;" target="_blank" title="new browser window"><span style="font-family: inherit;">FET - Future and Emerging Technologies </span></a></li>
<li style="background-color: #fefdfa; border-bottom-color: rgb(224, 224, 224); border-bottom-style: solid; border-width: 0px 0px 1px; color: #5d5d5d; font-family: arial, tahoma, helvetica, freesans, sans-serif; font-size: 13.2px; line-height: 1.25em; margin: 0px; padding: 0px;"><a class="arrow neues-fenster" href="http://ec.europa.eu/research/index.cfm?pg=why&lg=en" style="background-image: url("https://blogger.googleusercontent.com/img/proxy/AVvXsEj8Egaga9_6Q0rXdgohyphenhyphenYzB6-I5PW_2gxCEUP3GPYqD1HUQsskKiULEErhyphenhyphenbHLFOAq9af4ssGcbzHlI1orqxgB7n8mRK2k6FKBygWi7hu9qJbYXWpseUz2_mKL74DOJGxritIKAXGxGr3Mcm5jriAPBVx8rwHPIinj2a04e=s0-d"); background-position: 4px 0.82em; background-repeat: no-repeat; color: #2b6f93; display: block; padding: 0.5em 5px 0.5em 12px; text-decoration-line: none;" target="_blank" title="new browser window"><span style="font-family: inherit;">Why European Research?</span></a></li>
<li style="background-color: #fefdfa; border-bottom-color: rgb(224, 224, 224); border-bottom-style: solid; border-width: 0px 0px 1px; color: #5d5d5d; font-family: arial, tahoma, helvetica, freesans, sans-serif; font-size: 13.2px; line-height: 1.25em; margin: 0px; padding: 0px;"><a class="arrow neues-fenster" href="http://ec.europa.eu/research/era/index_en.htm" style="background-image: url("https://blogger.googleusercontent.com/img/proxy/AVvXsEj8Egaga9_6Q0rXdgohyphenhyphenYzB6-I5PW_2gxCEUP3GPYqD1HUQsskKiULEErhyphenhyphenbHLFOAq9af4ssGcbzHlI1orqxgB7n8mRK2k6FKBygWi7hu9qJbYXWpseUz2_mKL74DOJGxritIKAXGxGr3Mcm5jriAPBVx8rwHPIinj2a04e=s0-d"); background-position: 4px 0.82em; background-repeat: no-repeat; color: #2b6f93; display: block; padding: 0.5em 5px 0.5em 12px; text-decoration-line: none;" target="_blank" title="new browser window"><span style="font-family: inherit;">European Research Area (ERA)</span></a></li>
<li style="background-color: #fefdfa; border-bottom-color: rgb(224, 224, 224); border-bottom-style: solid; border-width: 0px 0px 1px; color: #5d5d5d; font-family: arial, tahoma, helvetica, freesans, sans-serif; font-size: 13.2px; line-height: 1.25em; margin: 0px; padding: 0px;"><a class="arrow neues-fenster" href="http://ec.europa.eu/research/index.cfm" style="background-image: url("https://blogger.googleusercontent.com/img/proxy/AVvXsEj8Egaga9_6Q0rXdgohyphenhyphenYzB6-I5PW_2gxCEUP3GPYqD1HUQsskKiULEErhyphenhyphenbHLFOAq9af4ssGcbzHlI1orqxgB7n8mRK2k6FKBygWi7hu9qJbYXWpseUz2_mKL74DOJGxritIKAXGxGr3Mcm5jriAPBVx8rwHPIinj2a04e=s0-d"); background-position: 4px 0.82em; background-repeat: no-repeat; color: #2b6f93; display: block; padding: 0.5em 5px 0.5em 12px; text-decoration-line: none;" target="_blank" title="new browser window"><span style="font-family: inherit;">Research at the European Commission</span></a></li>
<span style="background-color: #fefdfa; color: #5d5d5d; font-family: "arial" , "tahoma" , "helvetica" , "freesans" , sans-serif; font-size: 13.2px;"><br /></span><span style="background-color: white; color: #5d5d5d; font-family: "arial" , "tahoma" , "helvetica" , "freesans" , sans-serif; font-size: 13.2px;"></span><b style="background-color: #fefdfa; color: #5d5d5d; font-family: arial, tahoma, helvetica, freesans, sans-serif; font-size: 13.2px;"><br /></b><br />
<b style="background-color: #fefdfa; color: #5d5d5d;"><span style="font-family: inherit;">Sources</span></b><br />
<div style="text-align: left;">
</div>
<ul>
<li><span style="background-color: #fefdfa;"><span style="color: blue; font-family: inherit;"><a href="http://www.cost.eu/" target="_blank">Cost network</a></span></span></li>
<li><a href="http://www.cost.eu/COST_Actions/ca/CA15105" target="_blank"><span style="color: blue;">http://www.cost.eu/COST_Actions/ca/CA15105</span></a></li>
<li><span style="color: #666666;">Action Fact Sheet:</span> <a href="https://e-services.cost.eu/action/CA15105/download/AFS" style="color: #5d5d5d;" target="_blank">https://e-services.cost.eu/action/CA15105/download/AFS</a></li>
<li><span style="color: #666666;">Memorandum of Understanding:</span><b> </b><span style="color: #5d5d5d;"><a href="https://e-services.cost.eu/files/domain_files/CA/Action_CA15105/mou/CA15105-e.pdf" target="_blank">https://e-services.cost.eu/files/domain_files/CA/Action_CA15105/mou/CA15105-e.pdf</a></span></li>
<li><span style="color: #666666;">Cost Vademecum (s.p. 18 for reimbursement eligibility rules): </span> <span style="color: blue;"><a href="http://www.cost.eu/download/COSTVademecum" target="_blank">http://www.cost.eu/download/COSTVademecum</a></span></li>
</ul>
<div style="text-align: left;">
<b><span style="color: #3d85c6; font-family: inherit;"><a class="linkWithArrowBefore" href="https://www.gesundheit.bfh.ch/en/research/nutrition_and_dietetics/projects/cost_action_ca15105/how_to_participate.html" style="background-color: white; background-position: 0px 0px; background-repeat: no-repeat; padding-left: 18px;" target="_blank" title="Opens external link in new window">Participation</a></span></b></div>
</div>
Medicines Shortages in Europehttp://www.blogger.com/profile/07362716140541888698noreply@blogger.comtag:blogger.com,1999:blog-5764090054909858273.post-14201987720145001542018-01-20T11:22:00.001+01:002019-09-23T07:23:39.257+02:00Photos<div dir="ltr" style="text-align: left;" trbidi="on">
<b style="background-color: #fefdfa; color: #333333; font-family: Arial, Tahoma, Helvetica, FreeSans, sans-serif; font-size: 13px;"><b style="background-color: #fefdfa; color: #333333; font-family: Arial, Tahoma, Helvetica, FreeSans, sans-serif; font-size: 13px;"><u><br /></u></b></b>
<b style="background-color: #fefdfa; color: #333333; font-family: Arial, Tahoma, Helvetica, FreeSans, sans-serif; font-size: 13px;"><b style="background-color: #fefdfa; color: #333333; font-family: Arial, Tahoma, Helvetica, FreeSans, sans-serif; font-size: 13px;"><b style="background-color: #fefdfa; color: #333333; font-family: Arial, Tahoma, Helvetica, FreeSans, sans-serif; font-size: 13px;"><b style="background-color: #fefdfa; color: #333333; font-family: Arial, Tahoma, Helvetica, FreeSans, sans-serif; font-size: 13px;"><b style="background-color: #fefdfa; color: #333333; font-family: Arial, Tahoma, Helvetica, FreeSans, sans-serif; font-size: 13px;"><b style="background-color: #fefdfa; color: #333333; font-family: Arial, Tahoma, Helvetica, FreeSans, sans-serif; font-size: 13px;"><b style="background-color: #fefdfa; color: #333333; font-family: Arial, Tahoma, Helvetica, FreeSans, sans-serif; font-size: 13px;"><b style="background-color: #fefdfa; color: #333333; font-family: Arial, Tahoma, Helvetica, FreeSans, sans-serif; font-size: 13px;"><u>Meeting in Vilnius, 10-11 Sep 2019</u></b></b></b></b></b></b></b></b><br />
<div class="separator" style="clear: both; text-align: center;">
<a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhyP7gtvIw8boJGyGAJDKgL6-c5v4WCuBQeRbmfARzKg7yAWOyrCQ-E3urMBKoAjN_MgDOlBttIJ6ivxevKRr_iWhMoghGbbYvqhWGOItpIetdABk-kqRuCU5JcdzXrQAzWQLYo7IcgHKSY/s1600/DSC_7393.jpg" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img border="0" data-original-height="1097" data-original-width="1600" height="273" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhyP7gtvIw8boJGyGAJDKgL6-c5v4WCuBQeRbmfARzKg7yAWOyrCQ-E3urMBKoAjN_MgDOlBttIJ6ivxevKRr_iWhMoghGbbYvqhWGOItpIetdABk-kqRuCU5JcdzXrQAzWQLYo7IcgHKSY/s400/DSC_7393.jpg" width="400" /></a></div>
<b style="background-color: #fefdfa; color: #333333; font-family: Arial, Tahoma, Helvetica, FreeSans, sans-serif; font-size: 13px;"><b style="background-color: #fefdfa; color: #333333; font-family: Arial, Tahoma, Helvetica, FreeSans, sans-serif; font-size: 13px;"><u><br /></u></b></b>
<b style="background-color: #fefdfa; color: #333333; font-family: Arial, Tahoma, Helvetica, FreeSans, sans-serif; font-size: 13px;"><b style="background-color: #fefdfa; color: #333333; font-family: Arial, Tahoma, Helvetica, FreeSans, sans-serif; font-size: 13px;"><u><br /></u></b></b>
<b style="background-color: #fefdfa; color: #333333; font-family: Arial, Tahoma, Helvetica, FreeSans, sans-serif; font-size: 13px;"><b style="background-color: #fefdfa; color: #333333; font-family: Arial, Tahoma, Helvetica, FreeSans, sans-serif; font-size: 13px;"><u><br /></u></b></b>
<b style="background-color: #fefdfa; color: #333333; font-family: Arial, Tahoma, Helvetica, FreeSans, sans-serif; font-size: 13px;"><b style="background-color: #fefdfa; color: #333333; font-family: Arial, Tahoma, Helvetica, FreeSans, sans-serif; font-size: 13px;"><b style="background-color: #fefdfa; color: #333333; font-family: Arial, Tahoma, Helvetica, FreeSans, sans-serif; font-size: 13px;"><b style="background-color: #fefdfa; color: #333333; font-family: Arial, Tahoma, Helvetica, FreeSans, sans-serif; font-size: 13px;"><b style="background-color: #fefdfa; color: #333333; font-family: Arial, Tahoma, Helvetica, FreeSans, sans-serif; font-size: 13px;"><b style="background-color: #fefdfa; color: #333333; font-family: Arial, Tahoma, Helvetica, FreeSans, sans-serif; font-size: 13px;"><u>Meeting in Brussels, 22 Nov 2018</u></b></b></b></b></b></b><br />
<div class="separator" style="clear: both; text-align: center;">
<a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjNg6wL4IkRIqBm9DL7xKz8kgUM9uJTzLerbwBeZtks7XIuHWgj9AP8IUCv5NsrJwq2hyphenhyphenJ1IRvOVsSJoRMg6lsPlX3AV2P1XftV8jekOXi8YxG5wy3LLk5K86J7ZxoAPM7jZ8vNt2Um_GVx/s1600/IMG_7996.jpg" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img border="0" data-original-height="1200" data-original-width="1600" height="300" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjNg6wL4IkRIqBm9DL7xKz8kgUM9uJTzLerbwBeZtks7XIuHWgj9AP8IUCv5NsrJwq2hyphenhyphenJ1IRvOVsSJoRMg6lsPlX3AV2P1XftV8jekOXi8YxG5wy3LLk5K86J7ZxoAPM7jZ8vNt2Um_GVx/s400/IMG_7996.jpg" width="400" /></a></div>
<b style="background-color: #fefdfa; color: #333333; font-family: Arial, Tahoma, Helvetica, FreeSans, sans-serif; font-size: 13px;"><b style="background-color: #fefdfa; color: #333333; font-family: Arial, Tahoma, Helvetica, FreeSans, sans-serif; font-size: 13px;"><b style="background-color: #fefdfa; color: #333333; font-family: Arial, Tahoma, Helvetica, FreeSans, sans-serif; font-size: 13px;"><b style="background-color: #fefdfa; color: #333333; font-family: Arial, Tahoma, Helvetica, FreeSans, sans-serif; font-size: 13px;"><b style="background-color: #fefdfa; color: #333333; font-family: Arial, Tahoma, Helvetica, FreeSans, sans-serif; font-size: 13px;"><b style="background-color: #fefdfa; color: #333333; font-family: Arial, Tahoma, Helvetica, FreeSans, sans-serif; font-size: 13px;"><u><br /></u></b></b></b></b></b></b>
<br />
<div class="separator" style="clear: both; text-align: center;">
<a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEgm2R31vgTeQQFOUOkwzZxVZESYw78mYc1477weVyiV2OEx5fbZPox7IQI2zqXBpNzK1nlM-4UNiNlNrRh2FSIr9w6VwtD7dfDTd8a2O-_0Qbz7l6gNUTKD_R8Kvrme6jPSjqt92nkRZ5cG/s1600/IMG_7995.jpg" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img border="0" data-original-height="1200" data-original-width="1600" height="300" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEgm2R31vgTeQQFOUOkwzZxVZESYw78mYc1477weVyiV2OEx5fbZPox7IQI2zqXBpNzK1nlM-4UNiNlNrRh2FSIr9w6VwtD7dfDTd8a2O-_0Qbz7l6gNUTKD_R8Kvrme6jPSjqt92nkRZ5cG/s400/IMG_7995.jpg" width="400" /></a></div>
<b style="background-color: #fefdfa; color: #333333; font-family: Arial, Tahoma, Helvetica, FreeSans, sans-serif; font-size: 13px;"><b style="background-color: #fefdfa; color: #333333; font-family: Arial, Tahoma, Helvetica, FreeSans, sans-serif; font-size: 13px;"><b style="background-color: #fefdfa; color: #333333; font-family: Arial, Tahoma, Helvetica, FreeSans, sans-serif; font-size: 13px;"><b style="background-color: #fefdfa; color: #333333; font-family: Arial, Tahoma, Helvetica, FreeSans, sans-serif; font-size: 13px;"><b style="background-color: #fefdfa; color: #333333; font-family: Arial, Tahoma, Helvetica, FreeSans, sans-serif; font-size: 13px;"><b style="background-color: #fefdfa; color: #333333; font-family: Arial, Tahoma, Helvetica, FreeSans, sans-serif; font-size: 13px;"><u><br /></u></b></b></b></b></b></b>
<br />
<div class="separator" style="clear: both; text-align: center;">
<a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEiA9DbsbF24bpIXtaha0lL2B_8E2FZIIVxR1owHQ9Ck2CnjekIs8yy3AIjsM5fAD9u6RI_L1GlTN302QG8euphHMqtoYGjSqFPq7N7kq0F_fBS9UGd5tCAjr9Dx2RqmN1n1g9-F9kbG79d-/s1600/Brussels+22Nov18.jpeg" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img border="0" data-original-height="391" data-original-width="1199" height="130" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEiA9DbsbF24bpIXtaha0lL2B_8E2FZIIVxR1owHQ9Ck2CnjekIs8yy3AIjsM5fAD9u6RI_L1GlTN302QG8euphHMqtoYGjSqFPq7N7kq0F_fBS9UGd5tCAjr9Dx2RqmN1n1g9-F9kbG79d-/s400/Brussels+22Nov18.jpeg" width="400" /></a></div>
<b style="background-color: #fefdfa; color: #333333; font-family: Arial, Tahoma, Helvetica, FreeSans, sans-serif; font-size: 13px;"><b style="background-color: #fefdfa; color: #333333; font-family: Arial, Tahoma, Helvetica, FreeSans, sans-serif; font-size: 13px;"><u><br /></u></b></b>
<b style="background-color: #fefdfa; color: #333333; font-family: Arial, Tahoma, Helvetica, FreeSans, sans-serif; font-size: 13px;"><b style="background-color: #fefdfa; color: #333333; font-family: Arial, Tahoma, Helvetica, FreeSans, sans-serif; font-size: 13px;"><u><br /></u></b></b>
<b style="background-color: #fefdfa; color: #333333; font-family: Arial, Tahoma, Helvetica, FreeSans, sans-serif; font-size: 13px;"><b style="background-color: #fefdfa; color: #333333; font-family: Arial, Tahoma, Helvetica, FreeSans, sans-serif; font-size: 13px;"><b style="background-color: #fefdfa; color: #333333; font-family: Arial, Tahoma, Helvetica, FreeSans, sans-serif; font-size: 13px;"><b style="background-color: #fefdfa; color: #333333; font-family: Arial, Tahoma, Helvetica, FreeSans, sans-serif; font-size: 13px;"><u>Meeting in Brussels, 10-11 Apr 2018</u></b></b></b></b><br />
<div class="separator" style="clear: both; text-align: center;">
<a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjf9m1eYFdbeMq0ci-Xb4G4tc51OKr5qhnxX9bHLuiQ3sfzVBX9YVWTh40B1Vk0_MzV1Q9Nex6oVEKeB3wGnthpH9yQCNq7xB0kZnhF25QZ4seq1RxEdG_u1IoBbRe6em6ROYDCp3EKnEiV/s1600/IMG_5861.JPG" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img border="0" data-original-height="1200" data-original-width="1600" height="300" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjf9m1eYFdbeMq0ci-Xb4G4tc51OKr5qhnxX9bHLuiQ3sfzVBX9YVWTh40B1Vk0_MzV1Q9Nex6oVEKeB3wGnthpH9yQCNq7xB0kZnhF25QZ4seq1RxEdG_u1IoBbRe6em6ROYDCp3EKnEiV/s400/IMG_5861.JPG" width="400" /></a></div>
<br />
<div class="separator" style="clear: both; text-align: center;">
<a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEi_pklW4HBVPJ29rUzkhtwZKxRiPYph-yNSJPDLL75JnMSHa_2FAhZRmfvBo3rEOrCJw4ZrCbwv-WGWS3gGmVPoFh-bitHL-6oq9ohKku4x0eKAlb3WCaCuPoJmju_4631pd9DwOz47qhBN/s1600/IMG_5863.JPG" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img border="0" data-original-height="1200" data-original-width="1600" height="300" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEi_pklW4HBVPJ29rUzkhtwZKxRiPYph-yNSJPDLL75JnMSHa_2FAhZRmfvBo3rEOrCJw4ZrCbwv-WGWS3gGmVPoFh-bitHL-6oq9ohKku4x0eKAlb3WCaCuPoJmju_4631pd9DwOz47qhBN/s400/IMG_5863.JPG" width="400" /></a></div>
<b style="background-color: #fefdfa; color: #333333; font-family: Arial, Tahoma, Helvetica, FreeSans, sans-serif; font-size: 13px;"><b style="background-color: #fefdfa; color: #333333; font-family: Arial, Tahoma, Helvetica, FreeSans, sans-serif; font-size: 13px;"><b style="background-color: #fefdfa; color: #333333; font-family: Arial, Tahoma, Helvetica, FreeSans, sans-serif; font-size: 13px;"><b style="background-color: #fefdfa; color: #333333; font-family: Arial, Tahoma, Helvetica, FreeSans, sans-serif; font-size: 13px;"><u><br /></u></b></b></b></b>
<b style="background-color: #fefdfa; color: #333333; font-family: Arial, Tahoma, Helvetica, FreeSans, sans-serif; font-size: 13px;"><b style="background-color: #fefdfa; color: #333333; font-family: Arial, Tahoma, Helvetica, FreeSans, sans-serif; font-size: 13px;"><u><br /></u></b></b>
<b style="background-color: #fefdfa; color: #333333; font-family: Arial, Tahoma, Helvetica, FreeSans, sans-serif; font-size: 13px;"><b style="background-color: #fefdfa; color: #333333; font-family: Arial, Tahoma, Helvetica, FreeSans, sans-serif; font-size: 13px;"><u>Meeting in Krakow, 25 Jan 2018</u></b></b><br />
<div class="separator" style="clear: both; text-align: center;">
<a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEj_mcRDgCCi2gs-1w0BJQEWMjY5mqkS9QTCt7BnSeURR1hTNd1uImsZ6jxJXXadSPMHYCUjEJ1ivrldbc4RlavT_8fF6H0JmI5sxARDQoP6Mukom8_DbnmrePaZPJm4579O0twH8HvIGROY/s1600/IMG_5492.JPG" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img border="0" data-original-height="1200" data-original-width="1600" height="300" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEj_mcRDgCCi2gs-1w0BJQEWMjY5mqkS9QTCt7BnSeURR1hTNd1uImsZ6jxJXXadSPMHYCUjEJ1ivrldbc4RlavT_8fF6H0JmI5sxARDQoP6Mukom8_DbnmrePaZPJm4579O0twH8HvIGROY/s400/IMG_5492.JPG" width="400" /></a></div>
<b style="background-color: #fefdfa; color: #333333; font-family: arial, tahoma, helvetica, freesans, sans-serif; font-size: 13px;"><u><br /></u></b>
<b style="background-color: #fefdfa; color: #333333; font-family: arial, tahoma, helvetica, freesans, sans-serif; font-size: 13px;"><u>Meeting in Belgrade, 18 Jan 2018</u></b><br />
<div class="separator" style="clear: both; text-align: center;">
</div>
<div class="separator" style="clear: both; text-align: center;">
<a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEiJm_dd6zDX36xW_bAlwMlDnMYT32flVJlzNR8Dyuy5wNtXbVJc1agTzJoBfRWQF0_MAdCAak1ZcbWr-GHjqCs7S_vgYLzyTr3rAgEZH6NfeHJCo-wMn6wc_ywX9ZqWFsiEcQ2yT4xybcDC/s1600/Belgrade+2018.jpg" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img border="0" data-original-height="1200" data-original-width="1600" height="300" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEiJm_dd6zDX36xW_bAlwMlDnMYT32flVJlzNR8Dyuy5wNtXbVJc1agTzJoBfRWQF0_MAdCAak1ZcbWr-GHjqCs7S_vgYLzyTr3rAgEZH6NfeHJCo-wMn6wc_ywX9ZqWFsiEcQ2yT4xybcDC/s400/Belgrade+2018.jpg" width="400" /></a></div>
<b style="background-color: #fefdfa; color: #333333; font-family: Arial, Tahoma, Helvetica, FreeSans, sans-serif; font-size: 13px;"><u><br /></u></b>
<b style="background-color: #fefdfa; color: #333333; font-family: Arial, Tahoma, Helvetica, FreeSans, sans-serif; font-size: 13px;"><u>Meeting in Valetta, 12-13 Sep 2017</u></b><br />
<div class="separator" style="clear: both; text-align: center;">
<a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhGQp-Zp3fUxTyt3c1hFtxipYOg5NrqZ8-cfe2NzJBedRdbodnUAq2oMbxbC4KirEpl-JenkkyNc_WjuOCoW3QDUb_o7aisOgq1m_3E9FukEW0W3pD3uBkolCWJE95bOoigzJF3yYpUB1uD/s1600/Malta+Group+Photo+3.jpg" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img border="0" data-original-height="1200" data-original-width="1600" height="300" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhGQp-Zp3fUxTyt3c1hFtxipYOg5NrqZ8-cfe2NzJBedRdbodnUAq2oMbxbC4KirEpl-JenkkyNc_WjuOCoW3QDUb_o7aisOgq1m_3E9FukEW0W3pD3uBkolCWJE95bOoigzJF3yYpUB1uD/s400/Malta+Group+Photo+3.jpg" width="400" /></a></div>
<div class="separator" style="clear: both; text-align: center;">
</div>
<b style="background-color: #fefdfa; color: #333333; font-family: Arial, Tahoma, Helvetica, FreeSans, sans-serif; font-size: 13px;"><u><br /></u></b></div>
Medicines Shortages in Europehttp://www.blogger.com/profile/07362716140541888698noreply@blogger.comtag:blogger.com,1999:blog-5764090054909858273.post-15698599225733559652018-01-20T11:14:00.004+01:002021-03-18T19:11:42.180+01:00Meetings & events<div dir="ltr" style="text-align: left;" trbidi="on">
<span face=""arial" , "tahoma" , "helvetica" , "freesans" , sans-serif" style="background-color: #fefdfa; color: #333333; font-size: 13px;"><br /></span><span face=""arial" , "tahoma" , "helvetica" , "freesans" , sans-serif" style="background-color: #fefdfa; color: #333333; font-size: 13px;"><b>Upcoming meetings and events</b></span><br />
<span face=""arial" , "tahoma" , "helvetica" , "freesans" , sans-serif" style="background-color: #fefdfa; color: #333333; font-size: 13px;"><b><br /></b></span>
<span face=""arial" , "tahoma" , "helvetica" , "freesans" , sans-serif" style="color: #333333; font-size: 13px;">Final Meeting of COST Action CA15105 Medicines Shortages</span></div><div dir="ltr" style="text-align: left;" trbidi="on"><span face=""arial" , "tahoma" , "helvetica" , "freesans" , sans-serif" style="color: #333333; font-size: 13px;">26th of March 2021</span></div><div dir="ltr" style="text-align: left;" trbidi="on"><span face=""arial" , "tahoma" , "helvetica" , "freesans" , sans-serif" style="color: #333333; font-size: 13px;">On Teams platform</span><br />
<span face=""arial" , "tahoma" , "helvetica" , "freesans" , sans-serif" style="background-color: #fefdfa; color: #333333; font-size: 13px;"><br /></span>
<span face=""arial" , "tahoma" , "helvetica" , "freesans" , sans-serif" style="background-color: #fefdfa; color: #333333; font-size: 13px;"><b>Past meetings</b></span><br />
<span face=""arial" , "tahoma" , "helvetica" , "freesans" , sans-serif" style="background-color: #fefdfa; color: #333333; font-size: 13px;"><b><br /></b></span>
<span face=""arial" , "tahoma" , "helvetica" , "freesans" , sans-serif" style="color: #333333;"><span style="font-size: 13px;">Vilnius, Lithuania</span></span><br />
<span face=""arial" , "tahoma" , "helvetica" , "freesans" , sans-serif" style="color: #333333; font-size: 13px;">September 10-11, 2019</span><br />
<span face=""arial" , "tahoma" , "helvetica" , "freesans" , sans-serif" style="color: #333333; font-size: 13px;"><br /></span>
<span face=""arial" , "tahoma" , "helvetica" , "freesans" , sans-serif" style="background-color: #fefdfa; color: #333333; font-size: 13px;">Brussels, Belgium</span><br />
<span face=""arial" , "tahoma" , "helvetica" , "freesans" , sans-serif" style="color: #333333; font-size: 13px;">March 13-14, 2019</span><span face=""arial" , "tahoma" , "helvetica" , "freesans" , sans-serif" style="background-color: #fefdfa; color: #333333; font-size: 13px;"></span><br />
<span face=""arial" , "tahoma" , "helvetica" , "freesans" , sans-serif" style="color: #333333;"><span style="font-size: 13px;"><br /></span></span>
<span face=""arial" , "tahoma" , "helvetica" , "freesans" , sans-serif" style="background-color: #fefdfa; color: #333333; font-size: 13px;">Brussels, Belgium</span><br />
<span face=""arial" , "tahoma" , "helvetica" , "freesans" , sans-serif" style="color: #333333;"><span style="font-size: 13px;">November 2018 (2 days)</span></span><br />
<span face=""arial" , "tahoma" , "helvetica" , "freesans" , sans-serif" style="color: #333333;"><span style="font-size: 13px;"><br /></span></span>
<span face=""arial" , "tahoma" , "helvetica" , "freesans" , sans-serif" style="background-color: #fefdfa; color: #333333; font-size: 13px;"></span>
<span face=""arial" , "tahoma" , "helvetica" , "freesans" , sans-serif" style="color: #333333;"><span style="font-size: 13px;">Brussels, Belgium</span></span><br />
<span face=""arial" , "tahoma" , "helvetica" , "freesans" , sans-serif" style="color: #333333;"><span style="font-size: 13px;">April 2018 (2 days)</span></span><br />
<span face=""arial" , "tahoma" , "helvetica" , "freesans" , sans-serif" style="color: #333333;"><span style="font-size: 13px;"><br /></span></span>
<span face=""arial" , "tahoma" , "helvetica" , "freesans" , sans-serif" style="color: #333333; font-size: 13px;"></span>
<span face=""arial" , "tahoma" , "helvetica" , "freesans" , sans-serif" style="color: #333333; font-size: 13px;">Krakow, Poland</span><br />
<span face=""arial" , "tahoma" , "helvetica" , "freesans" , sans-serif" style="color: #333333; font-size: 13px;">January 2018</span><br />
<span face=""arial" , "tahoma" , "helvetica" , "freesans" , sans-serif" style="color: #333333;"><span style="font-size: 13px;"><br /></span></span>
<span face=""arial" , "tahoma" , "helvetica" , "freesans" , sans-serif" style="color: #333333;"><span style="font-size: 13px;">Belgrade, Serbia</span></span><br />
<span face=""arial" , "tahoma" , "helvetica" , "freesans" , sans-serif" style="color: #333333; font-size: 13px;">January 2018</span><br />
<span face=""arial" , "tahoma" , "helvetica" , "freesans" , sans-serif" style="background-color: #fefdfa; color: #333333; font-size: 13px;"><br /></span>
<span face=""arial" , "tahoma" , "helvetica" , "freesans" , sans-serif" style="color: #333333;"><span style="font-size: 13px;">Brussels, Belgium</span></span><br />
<span face=""arial" , "tahoma" , "helvetica" , "freesans" , sans-serif" style="color: #333333;"><span style="font-size: 13px;">January 2018</span></span><br />
<span face=""arial" , "tahoma" , "helvetica" , "freesans" , sans-serif" style="color: #333333;"><span style="font-size: 13px;"><br /></span></span>
<span face=""arial" , "tahoma" , "helvetica" , "freesans" , sans-serif" style="color: #333333;"><span style="font-size: 13px;">La Valetta, Malta</span></span><br />
<span face=""arial" , "tahoma" , "helvetica" , "freesans" , sans-serif" style="color: #333333;"><span style="font-size: 13px;">September 2017 (2 days)</span></span><br />
<span face=""arial" , "tahoma" , "helvetica" , "freesans" , sans-serif" style="background-color: #fefdfa; color: #333333; font-size: 13px;"><br /></span>
<span face=""arial" , "tahoma" , "helvetica" , "freesans" , sans-serif" style="color: #333333;"><span style="font-size: 13px;">Cannes, France</span></span><br />
<span face=""arial" , "tahoma" , "helvetica" , "freesans" , sans-serif" style="color: #333333;"><span style="font-size: 13px;">March 2017</span></span><br />
<span face=""arial" , "tahoma" , "helvetica" , "freesans" , sans-serif" style="background-color: #fefdfa; color: #333333; font-size: 13px;"><br /></span>
<span face=""arial" , "tahoma" , "helvetica" , "freesans" , sans-serif" style="color: #333333;"><span style="font-size: 13px;">Brussels, Belgium</span></span><br />
<span face=""arial" , "tahoma" , "helvetica" , "freesans" , sans-serif" style="color: #333333;"><span style="font-size: 13px;">January 2017</span></span><br />
<span face=""arial" , "tahoma" , "helvetica" , "freesans" , sans-serif" style="background-color: #fefdfa; color: #333333; font-size: 13px;"><br /></span>
<span face=""arial" , "tahoma" , "helvetica" , "freesans" , sans-serif" style="color: #333333; font-size: 13px;">Bucharest, Romania</span><br />
<span face=""arial" , "tahoma" , "helvetica" , "freesans" , sans-serif" style="color: #333333; font-size: 13px;">September 2016</span><br />
<span face=""arial" , "tahoma" , "helvetica" , "freesans" , sans-serif" style="color: #333333; font-size: 13px;"><br /></span>
<span face=""arial" , "tahoma" , "helvetica" , "freesans" , sans-serif" style="background-color: #fefdfa; color: #333333; font-size: 13px;"></span>
<span face=""arial" , "tahoma" , "helvetica" , "freesans" , sans-serif" style="background-color: #fefdfa; color: #333333; font-size: 13px;">Brussels</span><span face=""arial" , "tahoma" , "helvetica" , "freesans" , sans-serif" style="color: #333333; font-size: 13px;">, Belgium</span><br />
<span face=""arial" , "tahoma" , "helvetica" , "freesans" , sans-serif" style="color: #333333; font-size: 13px;">April 2016</span><br />
<span face=""arial" , "tahoma" , "helvetica" , "freesans" , sans-serif" style="color: #333333; font-size: 13px;"><br /></span>
<br />
<span face=""arial" , "tahoma" , "helvetica" , "freesans" , sans-serif" style="color: #333333;"><span style="font-size: 13px;"><br /></span></span>
<span face=""arial" , "tahoma" , "helvetica" , "freesans" , sans-serif" style="color: #333333;"><span style="font-size: 13px;"><br /></span></span>
<span face=""arial" , "tahoma" , "helvetica" , "freesans" , sans-serif" style="color: #333333;"><span style="font-size: 13px;"><br /></span></span>
<span face=""arial" , "tahoma" , "helvetica" , "freesans" , sans-serif" style="color: #333333;"><span style="font-size: 13px;"><br /></span></span>
<span face=""arial" , "tahoma" , "helvetica" , "freesans" , sans-serif" style="color: #333333; font-size: 13px;"><br /></span>
<span face=""arial" , "tahoma" , "helvetica" , "freesans" , sans-serif" style="color: #333333; font-size: 13px;"><br /></span>
</div>
Medicines Shortages in Europehttp://www.blogger.com/profile/07362716140541888698noreply@blogger.comtag:blogger.com,1999:blog-5764090054909858273.post-72447011408796038772018-01-20T11:11:00.007+01:002021-02-21T19:00:42.539+01:00Management Committee<div dir="ltr" style="text-align: left;" trbidi="on">
<br /><ul class="ul-table-03" style="-webkit-font-smoothing: antialiased; box-sizing: border-box; caret-color: rgb(115, 115, 115); color: #737373; font-family: Exo, sans-serif; font-size: 14px; list-style: outside none none; margin: 2rem 0px; padding: 0px; position: relative; text-rendering: optimizelegibility;">
<li style="-webkit-font-smoothing: antialiased; border-bottom-color: rgb(210, 210, 205); border-bottom-style: solid; border-bottom-width: 1px; border-bottom: 1px solid rgb(210, 210, 205); box-sizing: border-box; margin: 0px; padding: 0px; position: relative; text-rendering: optimizelegibility;"><div class="ul-table-03__col-01" style="-webkit-font-smoothing: antialiased; box-sizing: border-box; display: inline-block; padding: 1rem 2rem; position: relative; text-rendering: optimizelegibility; width: calc((-0.1px + 50%) - 4rem);">
Action Chair</div>
<div class="ul-table-03__col-02" style="-webkit-font-smoothing: antialiased; box-sizing: border-box; display: inline-block; padding: 1rem 2rem; position: relative; text-rendering: optimizelegibility; width: calc((-0.1px + 50%) - 4rem);"><a href="https://www.cost.eu/actions/CA15105/143940" style="-webkit-font-smoothing: antialiased; box-sizing: border-box; color: #444444; position: relative; text-decoration: none; text-rendering: optimizelegibility;">Dr Tomasz BOCHENEK</a></div>
</li>
<li style="-webkit-font-smoothing: antialiased; border-bottom-color: rgb(210, 210, 205); border-bottom-style: solid; border-bottom-width: 1px; border-bottom: 1px solid rgb(210, 210, 205); box-sizing: border-box; margin: 0px; padding: 0px; position: relative; text-rendering: optimizelegibility;"><div class="ul-table-03__col-01" style="-webkit-font-smoothing: antialiased; box-sizing: border-box; display: inline-block; padding: 1rem 2rem; position: relative; text-rendering: optimizelegibility; width: calc((-0.1px + 50%) - 4rem);">
Action Vice Chair</div>
<div class="ul-table-03__col-02" style="-webkit-font-smoothing: antialiased; box-sizing: border-box; display: inline-block; padding: 1rem 2rem; position: relative; text-rendering: optimizelegibility; width: calc((-0.1px + 50%) - 4rem);">
<a href="https://www.cost.eu/actions/CA15105/105170" style="-webkit-font-smoothing: antialiased; box-sizing: border-box; color: #444444; position: relative; text-decoration: none; text-rendering: optimizelegibility;">Prof Isabelle HUYS<span aria-hidden="true" class="fa fa-angle-down" style="box-sizing: border-box; color: #e1783c; display: inline-block; font-family: "font awesome 5 pro"; font-weight: 900; line-height: 1; margin-left: 1rem; position: relative;"></span></a></div>
</li>
</ul>
<h2 style="-webkit-font-smoothing: antialiased; box-sizing: border-box; caret-color: rgb(115, 115, 115); color: #737373; font-family: Exo, sans-serif; position: relative; text-rendering: optimizelegibility;">
Key Action Leadership Positions</h2>
<ul class="ul-table-03" style="-webkit-font-smoothing: antialiased; box-sizing: border-box; caret-color: rgb(115, 115, 115); color: #737373; font-family: Exo, sans-serif; font-size: 14px; list-style: outside none none; margin: 2rem 0px; padding: 0px; position: relative; text-rendering: optimizelegibility;"><li style="-webkit-font-smoothing: antialiased; border-bottom: 1px solid rgb(210, 210, 205); box-sizing: border-box; margin: 0px; padding: 0px; position: relative; text-rendering: optimizelegibility;"><div class="ul-table-03__col-01" style="-webkit-font-smoothing: antialiased; box-sizing: border-box; display: inline-block; padding: 1rem 2rem; position: relative; text-rendering: optimizelegibility; width: calc((-0.1px + 50%) - 4rem);">WG 1 - Definition</div><span> </span><div class="ul-table-03__col-02" style="-webkit-font-smoothing: antialiased; box-sizing: border-box; display: inline-block; padding: 1rem 2rem; position: relative; text-rendering: optimizelegibility; width: calc((-0.1px + 50%) - 4rem);"><a href="https://www.cost.eu/actions/CA15105/106599" style="-webkit-font-smoothing: antialiased; background: rgba(0, 0, 0, 0) none repeat scroll 0px 0px; box-sizing: border-box; color: #444444; position: relative; text-decoration: none; text-rendering: optimizelegibility;">Ms Baiba ZIEMELE<span> </span></a></div></li><li style="-webkit-font-smoothing: antialiased; border-bottom: 1px solid rgb(210, 210, 205); box-sizing: border-box; margin: 0px; padding: 0px; position: relative; text-rendering: optimizelegibility;"><div class="ul-table-03__col-01" style="-webkit-font-smoothing: antialiased; box-sizing: border-box; display: inline-block; padding: 1rem 2rem; position: relative; text-rendering: optimizelegibility; width: calc((-0.1px + 50%) - 4rem);">WG 2 - Supply side</div><span> </span><div class="ul-table-03__col-02" style="-webkit-font-smoothing: antialiased; box-sizing: border-box; display: inline-block; padding: 1rem 2rem; position: relative; text-rendering: optimizelegibility; width: calc((-0.1px + 50%) - 4rem);"><a href="https://www.cost.eu/actions/CA15105/108594" style="-webkit-font-smoothing: antialiased; background: rgba(0, 0, 0, 0) none repeat scroll 0px 0px; box-sizing: border-box; color: #444444; position: relative; text-decoration: none; text-rendering: optimizelegibility;">Ms Jane NICHOLSON<span> </span></a></div></li><li style="-webkit-font-smoothing: antialiased; border-bottom: 1px solid rgb(210, 210, 205); box-sizing: border-box; margin: 0px; padding: 0px; position: relative; text-rendering: optimizelegibility;"><div class="ul-table-03__col-01" style="-webkit-font-smoothing: antialiased; box-sizing: border-box; display: inline-block; padding: 1rem 2rem; position: relative; text-rendering: optimizelegibility; width: calc((-0.1px + 50%) - 4rem);">WG 3 - Demand side</div><span> </span><div class="ul-table-03__col-02" style="-webkit-font-smoothing: antialiased; box-sizing: border-box; display: inline-block; padding: 1rem 2rem; position: relative; text-rendering: optimizelegibility; width: calc((-0.1px + 50%) - 4rem);"><a href="https://www.cost.eu/actions/CA15105/110938" style="-webkit-font-smoothing: antialiased; background: rgba(0, 0, 0, 0) none repeat scroll 0px 0px; box-sizing: border-box; color: #444444; position: relative; text-decoration: none; text-rendering: optimizelegibility;">Mr Nenad MILJKOVIC<span> </span></a></div></li><li style="-webkit-font-smoothing: antialiased; border-bottom: 1px solid rgb(210, 210, 205); box-sizing: border-box; margin: 0px; padding: 0px; position: relative; text-rendering: optimizelegibility;"><div class="ul-table-03__col-01" style="-webkit-font-smoothing: antialiased; box-sizing: border-box; display: inline-block; padding: 1rem 2rem; position: relative; text-rendering: optimizelegibility; width: calc((-0.1px + 50%) - 4rem);">Grant Holder Scientific Representative</div><span> </span><div class="ul-table-03__col-02" style="-webkit-font-smoothing: antialiased; box-sizing: border-box; display: inline-block; padding: 1rem 2rem; position: relative; text-rendering: optimizelegibility; width: calc((-0.1px + 50%) - 4rem);"><a href="https://www.cost.eu/actions/CA15105/143940" style="-webkit-font-smoothing: antialiased; background: rgba(0, 0, 0, 0) none repeat scroll 0px 0px; box-sizing: border-box; color: #444444; position: relative; text-decoration: none; text-rendering: optimizelegibility;">Dr Tomasz BOCHENEK</a></div></li><li style="-webkit-font-smoothing: antialiased; border-bottom: 1px solid rgb(210, 210, 205); box-sizing: border-box; margin: 0px; padding: 0px; position: relative; text-rendering: optimizelegibility;"><div class="ul-table-03__col-01" style="-webkit-font-smoothing: antialiased; box-sizing: border-box; display: inline-block; padding: 1rem 2rem; position: relative; text-rendering: optimizelegibility; width: calc((-0.1px + 50%) - 4rem);">Science Communication Manager</div><span> </span><div class="ul-table-03__col-02" style="-webkit-font-smoothing: antialiased; box-sizing: border-box; display: inline-block; padding: 1rem 2rem; position: relative; text-rendering: optimizelegibility; width: calc((-0.1px + 50%) - 4rem);"><a href="https://www.cost.eu/actions/CA15105/85464" style="-webkit-font-smoothing: antialiased; background: rgba(0, 0, 0, 0) none repeat scroll 0px 0px; box-sizing: border-box; color: #444444; position: relative; text-decoration: none; text-rendering: optimizelegibility;">Dr Roberto FRONTINI</a></div></li><li style="-webkit-font-smoothing: antialiased; border-bottom: 1px solid rgb(210, 210, 205); box-sizing: border-box; margin: 0px; padding: 0px; position: relative; text-rendering: optimizelegibility;"><div class="ul-table-03__col-01" style="-webkit-font-smoothing: antialiased; box-sizing: border-box; display: inline-block; padding: 1rem 2rem; position: relative; text-rendering: optimizelegibility; width: calc((-0.1px + 50%) - 4rem);">STSM Coordinator</div><span> </span><div class="ul-table-03__col-02" style="-webkit-font-smoothing: antialiased; box-sizing: border-box; display: inline-block; padding: 1rem 2rem; position: relative; text-rendering: optimizelegibility; width: calc((-0.1px + 50%) - 4rem);"><a href="https://www.cost.eu/actions/CA15105/109439" style="-webkit-font-smoothing: antialiased; background: rgba(0, 0, 0, 0) none repeat scroll 0px 0px; box-sizing: border-box; color: #444444; position: relative; text-decoration: none; text-rendering: optimizelegibility;">Ms Darija KURUC POJE</a></div></li><li style="-webkit-font-smoothing: antialiased; border-bottom: 1px solid rgb(210, 210, 205); box-sizing: border-box; margin: 0px; padding: 0px; position: relative; text-rendering: optimizelegibility;"><div class="ul-table-03__col-01" style="-webkit-font-smoothing: antialiased; box-sizing: border-box; display: inline-block; padding: 1rem 2rem; position: relative; text-rendering: optimizelegibility; width: calc((-0.1px + 50%) - 4rem);">ITC Conference Manager</div><span> </span><div class="ul-table-03__col-02" style="-webkit-font-smoothing: antialiased; box-sizing: border-box; display: inline-block; padding: 1rem 2rem; position: relative; text-rendering: optimizelegibility; width: calc((-0.1px + 50%) - 4rem);"><a href="https://www.cost.eu/actions/CA15105/144637" style="-webkit-font-smoothing: antialiased; background: rgba(0, 0, 0, 0) none repeat scroll 0px 0px; box-sizing: border-box; color: #444444; position: relative; text-decoration: none; text-rendering: optimizelegibility;">Dr Aurelija BURINSKIENE</a></div></li><li style="-webkit-font-smoothing: antialiased; border-bottom-color: rgb(210, 210, 205); border-bottom-style: solid; border-bottom-width: 1px; border-bottom: 1px solid rgb(210, 210, 205); box-sizing: border-box; margin: 0px; padding: 0px; position: relative; text-rendering: optimizelegibility;">
<br /></li>
</ul>
<h2 style="-webkit-font-smoothing: antialiased; box-sizing: border-box; caret-color: rgb(115, 115, 115); color: #737373; font-family: Exo, sans-serif; position: relative; text-rendering: optimizelegibility;">
<span style="font-weight: normal;">COST Participants</span></h2><h2 style="-webkit-font-smoothing: antialiased; box-sizing: border-box; caret-color: rgb(115, 115, 115); color: #737373; font-family: Exo, sans-serif; position: relative; text-rendering: optimizelegibility;"><span style="font-weight: normal;"><span style="font-size: x-small;"> <span style="font-size: small;"> • Austria <span> </span><span> <span> </span><span> </span><span> </span><span> </span><span> </span><span> </span><span> </span></span>Ms Gunda GITTLER<br /> • Austria <span> </span><span> </span><span> </span><span> </span><span> </span><span> </span><span> </span>Ms Martina JESKE<br /> • Belgium <span> </span><span> </span><span> </span><span> </span><span> </span><span> </span><span> </span>Prof Isabelle HUYS<br /> • Belgium <span> </span><span> </span><span> </span><span> </span><span> </span><span> </span><span> </span>Prof Steven SIMOENS<br /> • Bosnia and Herzegovina <span> </span>Dr Lana NEZIC<br /> • Bosnia and Herzegovina Ms Vesna VUJIC-ALEKSIC<br /> • Bulgaria <span> </span><span> </span><span> </span><span> </span><span> </span><span> </span><span> </span>Prof Evgeni GRIGOROV<br /> • Croatia <span> </span><span> </span><span> </span><span> </span><span> </span><span> </span><span> </span>Dr Suzana MIMICA MATANOVIĆ<br /> • Croatia <span> </span><span> </span><span> </span><span> </span><span> </span><span> </span><span> </span>Ms Darija KURUC POJE<br /> • Cyprus <span> </span><span> </span><span> </span><span> </span><span> </span><span> </span><span> </span>Dr Panagiotis PETROU<br /> • Cyprus <span> </span><span> </span><span> </span><span> </span><span> </span><span> </span><span> </span>Mr Georgios SAVVA<br /> • Denmark <span> </span><span> </span><span> </span><span> </span><span> </span><span> </span>Dr Marianne Hald CLEMMENSEN<br /> • Denmark <span> </span><span> </span><span> </span><span> </span><span> </span><span> </span>Dr Trine KART<br /> • Estonia <span> </span><span> </span><span> </span><span> </span><span> </span><span> </span><span> </span>Ms Marika SAAR<br /> • Finland <span> </span><span> </span><span> </span><span> </span><span> </span><span> </span><span> </span>Dr Kati SARNOLA<br /> • France <span> </span><span> </span><span> </span><span> </span><span> </span><span> </span><span> </span>Dr Guillaume BÉRAUD<br /> • France <span> </span><span> </span><span> </span><span> </span><span> </span><span> </span><span> </span>Mr François HOUŸEZ<br /> • Germany <span> </span><span> </span><span> </span><span> </span><span> </span><span> </span>Dr Roberto FRONTINI<br /> • Greece <span> </span><span> </span><span> </span><span> </span><span> </span><span> </span><span> </span>Dr Leonidas TZIMIS<br /> • Greece <span> </span><span> </span><span> </span><span> </span><span> </span><span> </span><span> </span>Dr Mina GAGA<br /> • Hungary <span> </span><span> </span><span> </span><span> </span><span> </span><span> </span><span> </span>Dr Botond LAKATOS<br /> • Ireland <span> </span><span> </span><span> </span><span> </span><span> </span><span> </span><span> </span><span></span>Dr Vincent HARGADEN<br /> • Ireland <span> </span><span> </span><span> </span><span> </span><span> </span><span> </span><span> </span>Ms Joan PEPPARD<br /> • Israel <span> </span><span> </span><span> </span><span> </span><span> </span><span> </span><span> </span><span> </span>Ms Michal DAVIDESCU<br /> • Israel <span> </span><span> </span><span> </span><span> </span><span> </span><span> </span><span> </span><span> </span>Prof David SCHWARTZ<br /> • Italy <span> </span><span> </span><span> </span><span> </span><span> </span><span> </span><span> </span><span> </span><span></span>Dr Francesca VENTURINI<br /> • Italy <span> </span><span> </span><span> </span><span> </span><span> </span><span> </span><span> </span><span> </span>Prof Roy CERQUETI<br /> • Latvia <span> </span><span> </span><span> </span><span> </span><span> </span><span> </span><span> </span><span> </span>Dr Inese SVIESTIŅA<br /> • Latvia <span> </span><span> </span><span> </span><span> </span><span> </span><span> </span><span> </span> Ms Baiba ZIEMELE<br /> • Lithuania <span> </span><span> </span><span> </span><span> </span><span> </span><span> </span>Dr Aurelija BURINSKIENE<br /> • Malta <span> </span><span> </span><span> </span><span> </span><span> </span><span> </span><span> </span> Prof Claude FARRUGIA<br /> • Malta <span> </span><span> </span><span> </span><span> </span><span> </span><span> </span><span> </span><span> </span>Prof Lilian M. AZZOPARDI<br /> • Montenegro <span> </span><span> </span><span> </span><span> </span><span> </span>Prof Bogdan ASANIN<br /> • Montenegro <span> </span><span> </span><span> </span><span> </span><span> </span>Prof Natasa DUBORIJA-KOVACEVIC<br /> • Norway <span> </span><span> </span><span> </span><span> </span><span> </span><span> </span> Dr Kristian SVENDSEN<br /> • Norway <span> </span><span> </span><span> </span><span> </span><span> </span><span> </span><span> </span>Prof Marianne JAHRE<br /> • Poland <span> </span><span> </span><span> </span><span> </span><span> </span><span> </span><span> </span>Dr Agnieszka SKOWRON<br /> • Portugal <span> </span><span> </span><span> </span><span> </span><span> </span><span> </span> Prof João MIRANDA<br /> • Portugal <span> </span><span> </span><span> </span><span> </span><span> </span><span> </span> Prof Maria Helena BAPTISTA<br /> • Romania <span> </span><span> </span><span> </span><span> </span><span> </span><span> </span>Mr Ioan ANTOFIE<br /> • Romania <span> </span><span> </span><span> </span><span> </span><span> </span><span> </span>Mr Paul ANDREIANU<br /> • Serbia <span> </span><span> </span><span> </span><span> </span><span> </span><span> </span><span> </span>Mr Nenad MILJKOVIC<br /> • Serbia <span> </span><span> </span><span> </span><span> </span><span> </span><span> </span><span> </span>Ms Dragana RAJINAC<br /> • Slovakia <span> </span><span> </span><span> </span><span> </span><span> </span><span> </span><span> </span>Ms Katarina KOMENSKA<br /> • Slovenia <span> </span><span> </span><span> </span><span> </span><span> </span><span> </span> Mr Franci TRATAR<br /> • Spain <span> </span><span> </span><span> </span><span> </span><span> </span><span> </span><span> </span><span> </span>Dr Elena ATIENZA-MACIAS<br /> • Spain <span> </span><span> </span><span> </span><span> </span><span> </span><span> </span><span> </span> Prof Jaime ESPIN BALBINO<br /> • Switzerland <span> </span><span> </span><span> </span><span> </span><span> </span>Dr Maurizio BATTISTINI<br /> • Switzerland <span> </span><span> </span><span> </span><span> </span><span> </span>Prof Stefan GROESSER<br /> • Turkey <span> </span><span> </span><span> </span><span> </span><span> </span><span> </span><span> </span>Prof Yasemin CAYIR<br /> • United Kingdom <span> </span><span> </span><span> </span>Ms Jane NICHOLSON<br /> • United Kingdom <span> </span><span> </span><span> </span> Prof Philip HOWARD<br /><br /> • <b>Country <span> </span><span> </span><span> </span><span> </span><span> </span><span> </span>MC Substitute</b><br /><br /> • Belgium <span> </span><span> </span><span> </span><span> </span><span> </span><span> </span>Ms Elfi DE WEERDT<br /> • Croatia <span> </span><span> </span><span> </span><span> </span><span> </span><span> </span> Prof Ana BOROVECKI<br /> • Croatia <span> </span><span> </span><span> </span><span> </span><span> </span><span> </span> Prof Iskra Alexandra NOLA<br /> • Cyprus <span> </span><span> </span><span> </span><span> </span><span> </span><span> </span> Ms Elena KKOLOU<br /> • France <span> </span><span> </span><span> </span><span> </span><span> </span><span> </span> Mr Serri TRAORE<br /> • Greece <span> </span><span> </span><span> </span><span> </span><span> </span><span> </span>Dr Eleni RINAKI<br /> • Greece <span> </span><span> </span><span> </span><span> </span><span> </span><span> </span>Ms Despoina MAKRIDAKI<br /> • Ireland <span> </span><span> </span><span> </span><span> </span><span> </span><span> </span>Prof Sheila RYDER<br /> • Israel <span> </span><span> </span><span> </span><span> </span><span> </span><span> </span><span> </span>Mr Michael KHALEMSKY<br /> • Italy <span> </span><span> </span><span> </span><span> </span><span> </span><span> </span><span> </span><span> </span>Dr Piera POLIDORI<br /> • Italy <span> </span><span> </span><span> </span><span> </span><span> </span><span> </span><span> </span> Prof Emanuela DELBUFALO<br /> • Lithuania <span> </span><span> </span><span> </span><span> </span><span> </span> Prof Vida DAVIDAVICIENE<br /> • Malta <span> </span><span> </span><span> </span><span> </span><span> </span><span> </span><span> </span>Ms Miriam KERR<br /> • Montenegro <span> </span><span> </span><span> </span><span> </span> Ms Željka BEŠOVIĆ<br /> • Serbia <span> </span><span> </span><span> </span><span> </span><span> </span><span> </span><span> </span>Dr Veselin MITROVIC<br /> • Serbia <span> </span><span> </span><span> </span><span> </span><span> </span><span> </span><span> </span>Ms Jasminka DRAGIC<br /> • Spain <span> </span><span> </span><span> </span><span> </span><span> </span><span> </span><span> </span>Dr Iñigo DE MIGUEL BERIAIN<br /> • Switzerland <span> </span><span> </span><span> </span><span> </span> Dr Enea MARTINELLI<br /> • Switzerland <span> </span><span> </span><span> </span><span> </span> Dr Priska VONBACH<br /> • Switzerland <span> </span><span> </span><span> </span><span> </span> Prof Pascal BONNABRY<br /> • Turkey <span> </span><span> </span><span> </span><span> </span><span> </span><span> </span>Dr Ömer KARTAL<br /> • United Kingdom <span> </span><span> </span> Mr David PREECE<br /> • United Kingdom <span> </span><span> </span> Mr Nick KAYE<br /><br /><b>Main Contacts</b><br /><br />Dr Tomasz BOCHENEK<br />Action Chair<br />t.bochenek@uj.edu.pl<br /><br />Prof Isabelle HUYS<br />Action Vice Chair<br />isabelle.huys@kuleuven.be<br /><br />Dr Roberto FRONTINI<br />Science Communications Manager<br />frontini@gmx.de<br /><br />Dr Federica ORTELLI<br />Science officer<br />federica.ortelli@cost.eu<br /><br />Ms Katchamon NIMPRANG<br />Administrative officer<br />Katchamon.Nimprang@cost.eu</span></span><span style="font-size: small;"><br /> </span></span></h2><span style="font-size: small;">
</span><ul class="ul-table-03" style="-webkit-font-smoothing: antialiased; box-sizing: border-box; caret-color: rgb(115, 115, 115); color: #737373; font-family: Exo, sans-serif; list-style: outside none none; margin: 2rem 0px; padding: 0px; position: relative; text-rendering: optimizelegibility;"><span style="font-size: small;">
</span><li class="ul-table-03__head" style="-webkit-font-smoothing: antialiased; background-color: rgba(215, 210, 195, 0.2); border-bottom-color: rgb(210, 210, 205); border-bottom-style: solid; border-bottom-width: 1px; border-bottom: 1px solid rgb(210, 210, 205); box-sizing: border-box; margin: 0px; padding: 0px; position: relative; text-rendering: optimizelegibility;"><br /></li></ul></div>Medicines Shortages in Europehttp://www.blogger.com/profile/07362716140541888698noreply@blogger.comtag:blogger.com,1999:blog-5764090054909858273.post-48095477788564654382018-01-20T11:00:00.003+01:002018-06-26T11:41:07.973+02:00Parties<div dir="ltr" style="text-align: left;" trbidi="on">
<h3 class="post-title entry-title" itemprop="name" style="background-color: #fefdfa; color: #d52a33; font-family: Georgia, Utopia, "Palatino Linotype", Palatino, serif; font-size: 22px; font-stretch: normal; font-variant-east-asian: normal; font-variant-numeric: normal; font-weight: normal; line-height: normal; margin: 0px; position: relative;">
</h3>
<div class="post-body entry-content" id="post-body-1779949807181733786" itemprop="description articleBody" style="background-color: #fefdfa; line-height: 1.4; position: relative; width: 586px;">
<div dir="ltr" style="color: #333333; font-family: arial, tahoma, helvetica, freesans, sans-serif; font-size: 13px;" trbidi="on">
<table border="1" cellpadding="2" cellspacing="0" style="background-color: white; border-collapse: collapse; border: 1px solid rgb(255, 255, 255); color: black; font-family: arial, verdana, sans-serif; font-size: 16.0016px; width: 415.031px;"><colgroup><col width="40%"></col><col></col><col></col></colgroup><tbody>
<tr><th style="background-color: #ebe4e8; border: 1px solid rgb(255, 255, 255); font-size: 0.7em; padding: 0.2em 5px; vertical-align: top;">MoU</th><td style="background-color: #f5f1f3; border: 1px solid rgb(255, 255, 255); font-size: 0.7em; padding: 0.2em 5px; vertical-align: top;">037/15</td></tr>
<tr><th style="background-color: #ebe4e8; border: 1px solid rgb(255, 255, 255); font-size: 0.7em; padding: 0.2em 5px; vertical-align: top;">CSO Approval date</th><td style="background-color: #f5f1f3; border: 1px solid rgb(255, 255, 255); font-size: 0.7em; padding: 0.2em 5px; vertical-align: top;">30/10/2015</td></tr>
<tr><th style="background-color: #ebe4e8; border: 1px solid rgb(255, 255, 255); font-size: 0.7em; padding: 0.2em 5px; vertical-align: top;">Start of Action</th><td style="background-color: #f5f1f3; border: 1px solid rgb(255, 255, 255); font-size: 0.7em; padding: 0.2em 5px; vertical-align: top;">14/04/2016</td></tr>
<tr><th style="background-color: #ebe4e8; border: 1px solid rgb(255, 255, 255); font-size: 0.7em; padding: 0.2em 5px; vertical-align: top;">End of Action</th><td style="background-color: #f5f1f3; border: 1px solid rgb(255, 255, 255); font-size: 0.7em; padding: 0.2em 5px; vertical-align: top;">13/04/2020</td></tr>
</tbody></table>
<h2 style="border: 0px; color: #7a4a66; font-family: arial, verdana, sans-serif; font-size: 0.9em; font-stretch: normal; font-variant-east-asian: normal; font-variant-numeric: normal; line-height: 1.25em; margin: 1.3em 0px 0px; padding: 0px; position: relative;">
Participations</h2>
</div>
<div dir="ltr" style="color: #333333; font-family: arial, tahoma, helvetica, freesans, sans-serif; font-size: 13px;" trbidi="on">
<table border="1" cellpadding="2" cellspacing="0" style="background: rgb(255, 255, 255); border-collapse: collapse; border: 1px solid rgb(255, 255, 255); color: black; font-family: arial, verdana, sans-serif; font-size: 16.0016px; width: 415.2px;"><tbody>
<tr class="header"><th style="background: rgb(221, 208, 215); border: 1px solid rgb(255, 255, 255); font-size: 0.7em; padding: 0.2em 5px; text-align: left; vertical-align: top;">Country</th><th style="background: rgb(221, 208, 215); border: 1px solid rgb(255, 255, 255); font-size: 0.7em; padding: 0.2em 5px; text-align: left; vertical-align: top;">Date</th><th style="background: rgb(221, 208, 215); border: 1px solid rgb(255, 255, 255); font-size: 0.7em; padding: 0.2em 5px; text-align: left; vertical-align: top;">Status</th></tr>
<tr><th style="background: rgb(235, 228, 232); border: 1px solid rgb(255, 255, 255); font-size: 0.7em; padding: 0.2em 5px; text-align: left; vertical-align: top;"><a class="arrow" href="http://www.cost.eu/about_cost/cost_countries?countrycode=AT" style="background: url("../images/icons/arrow_orange.gif") 0px 0.32em no-repeat; color: #2b6f93; padding-left: 8px; text-decoration-line: none;">Austria</a></th><td style="background: rgb(245, 241, 243); border: 1px solid rgb(255, 255, 255); font-size: 0.7em; padding: 0.2em 5px; vertical-align: top;">21/06/2016</td><td style="background: rgb(245, 241, 243); border: 1px solid rgb(255, 255, 255); font-size: 0.7em; padding: 0.2em 5px; vertical-align: top;">Confirmed</td></tr>
<tr><th style="background: rgb(235, 228, 232); border: 1px solid rgb(255, 255, 255); font-size: 0.7em; padding: 0.2em 5px; text-align: left; vertical-align: top;"><a class="arrow" href="http://www.cost.eu/about_cost/cost_countries?countrycode=BE" style="background: url("../images/icons/arrow_orange.gif") 0px 0.32em no-repeat; color: #2b6f93; padding-left: 8px; text-decoration-line: none;">Belgium</a></th><td style="background: rgb(245, 241, 243); border: 1px solid rgb(255, 255, 255); font-size: 0.7em; padding: 0.2em 5px; vertical-align: top;">31/12/2015</td><td style="background: rgb(245, 241, 243); border: 1px solid rgb(255, 255, 255); font-size: 0.7em; padding: 0.2em 5px; vertical-align: top;">Confirmed</td></tr>
<tr><th style="background: rgb(235, 228, 232); border: 1px solid rgb(255, 255, 255); font-size: 0.7em; padding: 0.2em 5px; text-align: left; vertical-align: top;"><a class="arrow" href="http://www.cost.eu/about_cost/cost_countries?countrycode=BA" style="background: url("../images/icons/arrow_orange.gif") 0px 0.32em no-repeat; color: #2b6f93; padding-left: 8px; text-decoration-line: none;">Bosnia and Herzegovina</a></th><td style="background: rgb(245, 241, 243); border: 1px solid rgb(255, 255, 255); font-size: 0.7em; padding: 0.2em 5px; vertical-align: top;">18/02/2016</td><td style="background: rgb(245, 241, 243); border: 1px solid rgb(255, 255, 255); font-size: 0.7em; padding: 0.2em 5px; vertical-align: top;">Confirmed</td></tr>
<tr><th style="background: rgb(235, 228, 232); border: 1px solid rgb(255, 255, 255); font-size: 0.7em; padding: 0.2em 5px; text-align: left; vertical-align: top;"><a class="arrow" href="http://www.cost.eu/about_cost/cost_countries?countrycode=HR" style="background: url("../images/icons/arrow_orange.gif") 0px 0.32em no-repeat; color: #2b6f93; padding-left: 8px; text-decoration-line: none;">Croatia</a></th><td style="background: rgb(245, 241, 243); border: 1px solid rgb(255, 255, 255); font-size: 0.7em; padding: 0.2em 5px; vertical-align: top;">01/04/2016</td><td style="background: rgb(245, 241, 243); border: 1px solid rgb(255, 255, 255); font-size: 0.7em; padding: 0.2em 5px; vertical-align: top;">Confirmed</td></tr>
<tr><th style="background: rgb(235, 228, 232); border: 1px solid rgb(255, 255, 255); font-size: 0.7em; padding: 0.2em 5px; text-align: left; vertical-align: top;"><a class="arrow" href="http://www.cost.eu/about_cost/cost_countries?countrycode=CY" style="background: url("../images/icons/arrow_orange.gif") 0px 0.32em no-repeat; color: #2b6f93; padding-left: 8px; text-decoration-line: none;">Cyprus</a></th><td style="background: rgb(245, 241, 243); border: 1px solid rgb(255, 255, 255); font-size: 0.7em; padding: 0.2em 5px; vertical-align: top;">28/04/2016</td><td style="background: rgb(245, 241, 243); border: 1px solid rgb(255, 255, 255); font-size: 0.7em; padding: 0.2em 5px; vertical-align: top;">Confirmed</td></tr>
<tr><th style="background: rgb(235, 228, 232); border: 1px solid rgb(255, 255, 255); font-size: 0.7em; padding: 0.2em 5px; text-align: left; vertical-align: top;"><a class="arrow" href="http://www.cost.eu/about_cost/cost_countries?countrycode=DK" style="background: url("../images/icons/arrow_orange.gif") 0px 0.32em no-repeat; color: #2b6f93; padding-left: 8px; text-decoration-line: none;">Denmark</a></th><td style="background: rgb(245, 241, 243); border: 1px solid rgb(255, 255, 255); font-size: 0.7em; padding: 0.2em 5px; vertical-align: top;">07/01/2016</td><td style="background: rgb(245, 241, 243); border: 1px solid rgb(255, 255, 255); font-size: 0.7em; padding: 0.2em 5px; vertical-align: top;">Confirmed</td></tr>
<tr><th style="background: rgb(235, 228, 232); border: 1px solid rgb(255, 255, 255); font-size: 0.7em; padding: 0.2em 5px; text-align: left; vertical-align: top;"><a class="arrow" href="http://www.cost.eu/about_cost/cost_countries?countrycode=EE" style="background: url("../images/icons/arrow_orange.gif") 0px 0.32em no-repeat; color: #2b6f93; padding-left: 8px; text-decoration-line: none;">Estonia</a></th><td style="background: rgb(245, 241, 243); border: 1px solid rgb(255, 255, 255); font-size: 0.7em; padding: 0.2em 5px; vertical-align: top;">15/05/2018</td><td style="background: rgb(245, 241, 243); border: 1px solid rgb(255, 255, 255); font-size: 0.7em; padding: 0.2em 5px; vertical-align: top;">Confirmed</td></tr>
<tr><th style="background: rgb(235, 228, 232); border: 1px solid rgb(255, 255, 255); font-size: 0.7em; padding: 0.2em 5px; text-align: left; vertical-align: top;"><a class="arrow" href="http://www.cost.eu/about_cost/cost_countries?countrycode=FR" style="background: url("../images/icons/arrow_orange.gif") 0px 0.32em no-repeat; color: #2b6f93; padding-left: 8px; text-decoration-line: none;">France</a></th><td style="background: rgb(245, 241, 243); border: 1px solid rgb(255, 255, 255); font-size: 0.7em; padding: 0.2em 5px; vertical-align: top;">27/04/2016</td><td style="background: rgb(245, 241, 243); border: 1px solid rgb(255, 255, 255); font-size: 0.7em; padding: 0.2em 5px; vertical-align: top;">Confirmed</td></tr>
<tr><th style="background: rgb(235, 228, 232); border: 1px solid rgb(255, 255, 255); font-size: 0.7em; padding: 0.2em 5px; text-align: left; vertical-align: top;"><a class="arrow" href="http://www.cost.eu/about_cost/cost_countries?countrycode=DE" style="background: url("../images/icons/arrow_orange.gif") 0px 0.32em no-repeat; color: #2b6f93; padding-left: 8px; text-decoration-line: none;">Germany</a></th><td style="background: rgb(245, 241, 243); border: 1px solid rgb(255, 255, 255); font-size: 0.7em; padding: 0.2em 5px; vertical-align: top;">24/11/2015</td><td style="background: rgb(245, 241, 243); border: 1px solid rgb(255, 255, 255); font-size: 0.7em; padding: 0.2em 5px; vertical-align: top;">Confirmed</td></tr>
<tr><th style="background: rgb(235, 228, 232); border: 1px solid rgb(255, 255, 255); font-size: 0.7em; padding: 0.2em 5px; text-align: left; vertical-align: top;"><a class="arrow" href="http://www.cost.eu/about_cost/cost_countries?countrycode=EL" style="background: url("../images/icons/arrow_orange.gif") 0px 0.32em no-repeat; color: #2b6f93; padding-left: 8px; text-decoration-line: none;">Greece</a></th><td style="background: rgb(245, 241, 243); border: 1px solid rgb(255, 255, 255); font-size: 0.7em; padding: 0.2em 5px; vertical-align: top;">24/11/2015</td><td style="background: rgb(245, 241, 243); border: 1px solid rgb(255, 255, 255); font-size: 0.7em; padding: 0.2em 5px; vertical-align: top;">Confirmed</td></tr>
<tr><th style="background: rgb(235, 228, 232); border: 1px solid rgb(255, 255, 255); font-size: 0.7em; padding: 0.2em 5px; text-align: left; vertical-align: top;"><a class="arrow" href="http://www.cost.eu/about_cost/cost_countries?countrycode=HU" style="background: url("../images/icons/arrow_orange.gif") 0px 0.32em no-repeat; color: #2b6f93; padding-left: 8px; text-decoration-line: none;">Hungary</a></th><td style="background: rgb(245, 241, 243); border: 1px solid rgb(255, 255, 255); font-size: 0.7em; padding: 0.2em 5px; vertical-align: top;">30/12/2016</td><td style="background: rgb(245, 241, 243); border: 1px solid rgb(255, 255, 255); font-size: 0.7em; padding: 0.2em 5px; vertical-align: top;">Confirmed</td></tr>
<tr><th style="background: rgb(235, 228, 232); border: 1px solid rgb(255, 255, 255); font-size: 0.7em; padding: 0.2em 5px; text-align: left; vertical-align: top;"><a class="arrow" href="http://www.cost.eu/about_cost/cost_countries?countrycode=IE" style="background: url("../images/icons/arrow_orange.gif") 0px 0.32em no-repeat; color: #2b6f93; padding-left: 8px; text-decoration-line: none;">Ireland</a></th><td style="background: rgb(245, 241, 243); border: 1px solid rgb(255, 255, 255); font-size: 0.7em; padding: 0.2em 5px; vertical-align: top;">04/04/2016</td><td style="background: rgb(245, 241, 243); border: 1px solid rgb(255, 255, 255); font-size: 0.7em; padding: 0.2em 5px; vertical-align: top;">Confirmed</td></tr>
<tr><th style="background: rgb(235, 228, 232); border: 1px solid rgb(255, 255, 255); font-size: 0.7em; padding: 0.2em 5px; text-align: left; vertical-align: top;"><a class="arrow" href="http://www.cost.eu/about_cost/cost_countries?countrycode=IL" style="background: url("../images/icons/arrow_orange.gif") 0px 0.32em no-repeat; color: #2b6f93; padding-left: 8px; text-decoration-line: none;">Israel</a></th><td style="background: rgb(245, 241, 243); border: 1px solid rgb(255, 255, 255); font-size: 0.7em; padding: 0.2em 5px; vertical-align: top;">02/02/2016</td><td style="background: rgb(245, 241, 243); border: 1px solid rgb(255, 255, 255); font-size: 0.7em; padding: 0.2em 5px; vertical-align: top;">Confirmed</td></tr>
<tr><th style="background: rgb(235, 228, 232); border: 1px solid rgb(255, 255, 255); font-size: 0.7em; padding: 0.2em 5px; text-align: left; vertical-align: top;"><a class="arrow" href="http://www.cost.eu/about_cost/cost_countries?countrycode=IT" style="background: url("../images/icons/arrow_orange.gif") 0px 0.32em no-repeat; color: #2b6f93; padding-left: 8px; text-decoration-line: none;">Italy</a></th><td style="background: rgb(245, 241, 243); border: 1px solid rgb(255, 255, 255); font-size: 0.7em; padding: 0.2em 5px; vertical-align: top;">15/12/2016</td><td style="background: rgb(245, 241, 243); border: 1px solid rgb(255, 255, 255); font-size: 0.7em; padding: 0.2em 5px; vertical-align: top;">Confirmed</td></tr>
<tr><th style="background: rgb(235, 228, 232); border: 1px solid rgb(255, 255, 255); font-size: 0.7em; padding: 0.2em 5px; text-align: left; vertical-align: top;"><a class="arrow" href="http://www.cost.eu/about_cost/cost_countries?countrycode=LV" style="background: url("../images/icons/arrow_orange.gif") 0px 0.32em no-repeat; color: #2b6f93; padding-left: 8px; text-decoration-line: none;">Latvia</a></th><td style="background: rgb(245, 241, 243); border: 1px solid rgb(255, 255, 255); font-size: 0.7em; padding: 0.2em 5px; vertical-align: top;">28/04/2016</td><td style="background: rgb(245, 241, 243); border: 1px solid rgb(255, 255, 255); font-size: 0.7em; padding: 0.2em 5px; vertical-align: top;">Confirmed</td></tr>
<tr><th style="background: rgb(235, 228, 232); border: 1px solid rgb(255, 255, 255); font-size: 0.7em; padding: 0.2em 5px; text-align: left; vertical-align: top;"><a class="arrow" href="http://www.cost.eu/about_cost/cost_countries?countrycode=LT" style="background: url("../images/icons/arrow_orange.gif") 0px 0.32em no-repeat; color: #2b6f93; padding-left: 8px; text-decoration-line: none;">Lithuania</a></th><td style="background: rgb(245, 241, 243); border: 1px solid rgb(255, 255, 255); font-size: 0.7em; padding: 0.2em 5px; vertical-align: top;">31/03/2017</td><td style="background: rgb(245, 241, 243); border: 1px solid rgb(255, 255, 255); font-size: 0.7em; padding: 0.2em 5px; vertical-align: top;">Confirmed</td></tr>
<tr><th style="background: rgb(235, 228, 232); border: 1px solid rgb(255, 255, 255); font-size: 0.7em; padding: 0.2em 5px; text-align: left; vertical-align: top;"><a class="arrow" href="http://www.cost.eu/about_cost/cost_countries?countrycode=MT" style="background: url("../images/icons/arrow_orange.gif") 0px 0.32em no-repeat; color: #2b6f93; padding-left: 8px; text-decoration-line: none;">Malta</a></th><td style="background: rgb(245, 241, 243); border: 1px solid rgb(255, 255, 255); font-size: 0.7em; padding: 0.2em 5px; vertical-align: top;">28/11/2015</td><td style="background: rgb(245, 241, 243); border: 1px solid rgb(255, 255, 255); font-size: 0.7em; padding: 0.2em 5px; vertical-align: top;">Confirmed</td></tr>
<tr><th style="background: rgb(235, 228, 232); border: 1px solid rgb(255, 255, 255); font-size: 0.7em; padding: 0.2em 5px; text-align: left; vertical-align: top;"><a class="arrow" href="http://www.cost.eu/about_cost/cost_countries?countrycode=ME" style="background: url("../images/icons/arrow_orange.gif") 0px 0.32em no-repeat; color: #2b6f93; padding-left: 8px; text-decoration-line: none;">Montenegro</a></th><td style="background: rgb(245, 241, 243); border: 1px solid rgb(255, 255, 255); font-size: 0.7em; padding: 0.2em 5px; vertical-align: top;">08/03/2016</td><td style="background: rgb(245, 241, 243); border: 1px solid rgb(255, 255, 255); font-size: 0.7em; padding: 0.2em 5px; vertical-align: top;">Confirmed</td></tr>
<tr><th style="background: rgb(235, 228, 232); border: 1px solid rgb(255, 255, 255); font-size: 0.7em; padding: 0.2em 5px; text-align: left; vertical-align: top;"><a class="arrow" href="http://www.cost.eu/about_cost/cost_countries?countrycode=NO" style="background: url("../images/icons/arrow_orange.gif") 0px 0.32em no-repeat; color: #2b6f93; padding-left: 8px; text-decoration-line: none;">Norway</a></th><td style="background: rgb(245, 241, 243); border: 1px solid rgb(255, 255, 255); font-size: 0.7em; padding: 0.2em 5px; vertical-align: top;">22/08/2017</td><td style="background: rgb(245, 241, 243); border: 1px solid rgb(255, 255, 255); font-size: 0.7em; padding: 0.2em 5px; vertical-align: top;">Confirmed</td></tr>
<tr><th style="background: rgb(235, 228, 232); border: 1px solid rgb(255, 255, 255); font-size: 0.7em; padding: 0.2em 5px; text-align: left; vertical-align: top;"><a class="arrow" href="http://www.cost.eu/about_cost/cost_countries?countrycode=PL" style="background: url("../images/icons/arrow_orange.gif") 0px 0.32em no-repeat; color: #2b6f93; padding-left: 8px; text-decoration-line: none;">Poland</a></th><td style="background: rgb(245, 241, 243); border: 1px solid rgb(255, 255, 255); font-size: 0.7em; padding: 0.2em 5px; vertical-align: top;">03/03/2016</td><td style="background: rgb(245, 241, 243); border: 1px solid rgb(255, 255, 255); font-size: 0.7em; padding: 0.2em 5px; vertical-align: top;">Confirmed</td></tr>
<tr><th style="background: rgb(235, 228, 232); border: 1px solid rgb(255, 255, 255); font-size: 0.7em; padding: 0.2em 5px; text-align: left; vertical-align: top;"><a class="arrow" href="http://www.cost.eu/about_cost/cost_countries?countrycode=PT" style="background: url("../images/icons/arrow_orange.gif") 0px 0.32em no-repeat; color: #2b6f93; padding-left: 8px; text-decoration-line: none;">Portugal</a></th><td style="background: rgb(245, 241, 243); border: 1px solid rgb(255, 255, 255); font-size: 0.7em; padding: 0.2em 5px; vertical-align: top;">26/04/2016</td><td style="background: rgb(245, 241, 243); border: 1px solid rgb(255, 255, 255); font-size: 0.7em; padding: 0.2em 5px; vertical-align: top;">Confirmed</td></tr>
<tr><th style="background: rgb(235, 228, 232); border: 1px solid rgb(255, 255, 255); font-size: 0.7em; padding: 0.2em 5px; text-align: left; vertical-align: top;"><a class="arrow" href="http://www.cost.eu/about_cost/cost_countries?countrycode=RO" style="background: url("../images/icons/arrow_orange.gif") 0px 0.32em no-repeat; color: #2b6f93; padding-left: 8px; text-decoration-line: none;">Romania</a></th><td style="background: rgb(245, 241, 243); border: 1px solid rgb(255, 255, 255); font-size: 0.7em; padding: 0.2em 5px; vertical-align: top;">30/05/2016</td><td style="background: rgb(245, 241, 243); border: 1px solid rgb(255, 255, 255); font-size: 0.7em; padding: 0.2em 5px; vertical-align: top;">Confirmed</td></tr>
<tr><th style="background: rgb(235, 228, 232); border: 1px solid rgb(255, 255, 255); font-size: 0.7em; padding: 0.2em 5px; text-align: left; vertical-align: top;"><a class="arrow" href="http://www.cost.eu/about_cost/cost_countries?countrycode=RS" style="background: url("../images/icons/arrow_orange.gif") 0px 0.32em no-repeat; color: #2b6f93; padding-left: 8px; text-decoration-line: none;">Serbia</a></th><td style="background: rgb(245, 241, 243); border: 1px solid rgb(255, 255, 255); font-size: 0.7em; padding: 0.2em 5px; vertical-align: top;">08/02/2016</td><td style="background: rgb(245, 241, 243); border: 1px solid rgb(255, 255, 255); font-size: 0.7em; padding: 0.2em 5px; vertical-align: top;">Confirmed</td></tr>
<tr><th style="background: rgb(235, 228, 232); border: 1px solid rgb(255, 255, 255); font-size: 0.7em; padding: 0.2em 5px; text-align: left; vertical-align: top;"><a class="arrow" href="http://www.cost.eu/about_cost/cost_countries?countrycode=SI" style="background: url("../images/icons/arrow_orange.gif") 0px 0.32em no-repeat; color: #2b6f93; padding-left: 8px; text-decoration-line: none;">Slovenia</a></th><td style="background: rgb(245, 241, 243); border: 1px solid rgb(255, 255, 255); font-size: 0.7em; padding: 0.2em 5px; vertical-align: top;">15/11/2015</td><td style="background: rgb(245, 241, 243); border: 1px solid rgb(255, 255, 255); font-size: 0.7em; padding: 0.2em 5px; vertical-align: top;">Confirmed</td></tr>
<tr><th style="background: rgb(235, 228, 232); border: 1px solid rgb(255, 255, 255); font-size: 0.7em; padding: 0.2em 5px; text-align: left; vertical-align: top;"><a class="arrow" href="http://www.cost.eu/about_cost/cost_countries?countrycode=ES" style="background: url("../images/icons/arrow_orange.gif") 0px 0.32em no-repeat; color: #2b6f93; padding-left: 8px; text-decoration-line: none;">Spain</a></th><td style="background: rgb(245, 241, 243); border: 1px solid rgb(255, 255, 255); font-size: 0.7em; padding: 0.2em 5px; vertical-align: top;">25/02/2016</td><td style="background: rgb(245, 241, 243); border: 1px solid rgb(255, 255, 255); font-size: 0.7em; padding: 0.2em 5px; vertical-align: top;">Confirmed</td></tr>
<tr><th style="background: rgb(235, 228, 232); border: 1px solid rgb(255, 255, 255); font-size: 0.7em; padding: 0.2em 5px; text-align: left; vertical-align: top;"><a class="arrow" href="http://www.cost.eu/about_cost/cost_countries?countrycode=CH" style="background: url("../images/icons/arrow_orange.gif") 0px 0.32em no-repeat; color: #2b6f93; padding-left: 8px; text-decoration-line: none;">Switzerland</a></th><td style="background: rgb(245, 241, 243); border: 1px solid rgb(255, 255, 255); font-size: 0.7em; padding: 0.2em 5px; vertical-align: top;">21/01/2016</td><td style="background: rgb(245, 241, 243); border: 1px solid rgb(255, 255, 255); font-size: 0.7em; padding: 0.2em 5px; vertical-align: top;">Confirmed</td></tr>
<tr><th style="background: rgb(235, 228, 232); border: 1px solid rgb(255, 255, 255); font-size: 0.7em; padding: 0.2em 5px; text-align: left; vertical-align: top;"><a class="arrow" href="http://www.cost.eu/about_cost/cost_countries?countrycode=UK" style="background: url("../images/icons/arrow_orange.gif") 0px 0.32em no-repeat; color: #2b6f93; padding-left: 8px; text-decoration-line: none;">United Kingdom</a></th><td style="background: rgb(245, 241, 243); border: 1px solid rgb(255, 255, 255); font-size: 0.7em; padding: 0.2em 5px; vertical-align: top;">16/11/2015</td><td style="background: rgb(245, 241, 243); border: 1px solid rgb(255, 255, 255); font-size: 0.7em; padding: 0.2em 5px; vertical-align: top;">Confirmed</td></tr>
</tbody></table>
<div class="table-footer" style="background: rgb(221, 208, 215); border: 0px; color: black; font-family: arial, verdana, sans-serif; font-size: 0.7em; font-weight: bold; line-height: 1.3em; margin-right: 1px; padding: 0.2em 5px 0.3em;">
Total: 27</div>
<h2 style="border: 0px; color: #7a4a66; font-family: arial, verdana, sans-serif; font-size: 0.9em; font-stretch: normal; line-height: 1.25em; margin: 1.3em 0px 0px; padding: 0px; position: relative;">
<br /></h2>
<b>Sourse</b></div>
<div dir="ltr" trbidi="on">
<span style="color: #333333; font-family: "arial" , "tahoma" , "helvetica" , "freesans" , sans-serif;"><span style="font-size: 13px;"><a href="http://www.cost.eu/COST_Actions/ca/CA15105?parties" target="_blank">http://www.cost.eu/COST_Actions/ca/CA15105?parties</a></span></span></div>
</div>
</div>
Medicines Shortages in Europehttp://www.blogger.com/profile/07362716140541888698noreply@blogger.comtag:blogger.com,1999:blog-5764090054909858273.post-86584286878171683102018-01-20T10:55:00.007+01:002021-03-26T08:19:26.509+01:00Publications<div dir="ltr" style="text-align: left;" trbidi="on">
<br />
<div class="separator" style="clear: both; text-align: center;">
<a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEidNIeIltpC8ex-VYecQFl1RZm7ek2IZazZrE8Ify2v6nwEB7YRtizwM91IJKRa8XlqAk7NMDkPfVtFL4CwlVGnNrbejUjEz9zAQzyJ4mHBblOqDg4PHa8-Rq6vBsWE4Ulh0mNMxHPgrA41/s1600/Logo_Cost_EU_Web_200px.jpg" style="clear: left; float: left; margin-bottom: 1em; margin-right: 1em;"><img border="0" data-original-height="41" data-original-width="200" height="40" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEidNIeIltpC8ex-VYecQFl1RZm7ek2IZazZrE8Ify2v6nwEB7YRtizwM91IJKRa8XlqAk7NMDkPfVtFL4CwlVGnNrbejUjEz9zAQzyJ4mHBblOqDg4PHa8-Rq6vBsWE4Ulh0mNMxHPgrA41/s200/Logo_Cost_EU_Web_200px.jpg" width="200" /></a></div>
<b style="background-color: #fefdfa; color: #5d5d5d; font-family: arial, tahoma, helvetica, freesans, sans-serif; font-size: 13.2px;">European Medicines Shortages Research Network - addressing supply problems to patients (Medicines Shortages) </b><br />
<br style="background-color: #fefdfa; color: #5d5d5d; font-family: arial, tahoma, helvetica, freesans, sans-serif; font-size: 13.2px;" />
</div><div dir="ltr" style="text-align: left;" trbidi="on"><br /></div><div class="separator" style="clear: both; text-align: center;"><a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEju7nRkPKQ58v8Rfdbp0qUAAsN-mmiLiPsj84A_W2BmYIkWg_OIr_L7VmoqjctCixPiM0YQ04TbFsC5Q8IfZCCwiVegiIo0pnfGDVKnHE-uN0qkQFSND-Pj_RlGZb4EAZeDAKAeB6sLDoL1/s892/Nenad_toolkit.jpg" style="clear: left; float: left; margin-bottom: 1em; margin-right: 1em;"><img border="0" data-original-height="892" data-original-width="633" height="200" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEju7nRkPKQ58v8Rfdbp0qUAAsN-mmiLiPsj84A_W2BmYIkWg_OIr_L7VmoqjctCixPiM0YQ04TbFsC5Q8IfZCCwiVegiIo0pnfGDVKnHE-uN0qkQFSND-Pj_RlGZb4EAZeDAKAeB6sLDoL1/w142-h200/Nenad_toolkit.jpg" width="142" /></a></div><h2 style="border-bottom: 1px solid transparent; color: #333333; font-family: Arial, Tahoma, Helvetica, FreeSans, sans-serif; font-size: 14px; font-stretch: normal; font-variant-east-asian: normal; font-variant-numeric: normal; line-height: normal; margin: 0px; padding: 0.6em 0px 0.5em; position: relative;">A Toolkit for Managing Shortages</h2><div><br /></div><div dir="ltr" style="text-align: left;" trbidi="on">Nenad Miljković, Brian Godman, Tomasz Bochenek, Isabelle Huys</div><div dir="ltr" style="text-align: left;" trbidi="on"><br /></div><div dir="ltr" style="text-align: left;" trbidi="on">To view the Toolkit, please click <b><a href="https://drive.google.com/file/d/1QmtCn9I-SYxkxzL4SglntpsBSrCTKHeR/view?usp=sharing" target="_blank">here</a></b>:</div><div dir="ltr" style="text-align: left;" trbidi="on"><br /></div><div dir="ltr" style="text-align: left;" trbidi="on"><a href="https://drive.google.com/file/d/1QmtCn9I-SYxkxzL4SglntpsBSrCTKHeR/view?usp=sharing" target="_blank">https://drive.google.com/file/d/1QmtCn9I-SYxkxzL4SglntpsBSrCTKHeR/view?usp=sharing</a></div><div><br /></div><div dir="ltr" style="text-align: left;" trbidi="on"><br /></div><div dir="ltr" style="text-align: left;" trbidi="on"><br /></div><div dir="ltr" style="text-align: left;" trbidi="on"><br /></div><div dir="ltr" style="text-align: left;" trbidi="on">###</div><div dir="ltr" style="text-align: left;" trbidi="on"><br /></div><div dir="ltr" style="text-align: left;" trbidi="on"><div class="separator" style="clear: both; text-align: center;"><a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhkG9qXRVI7j8E7kLjM5AmtgTFNoa8gW4KD_K2yXeP-U5dOkcY0nJZ1js5PI3o2nrRMfykc3ZaPqMotpefcRCtIAH2JC6lSfHK5GWUE-Aosk-wOhyh5v8rLo4bFyTwZN4PIi02wOTYRKRTy/s677/cover.png" style="clear: left; float: left; margin-bottom: 1em; margin-right: 1em;"><img border="0" data-original-height="677" data-original-width="480" height="200" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhkG9qXRVI7j8E7kLjM5AmtgTFNoa8gW4KD_K2yXeP-U5dOkcY0nJZ1js5PI3o2nrRMfykc3ZaPqMotpefcRCtIAH2JC6lSfHK5GWUE-Aosk-wOhyh5v8rLo4bFyTwZN4PIi02wOTYRKRTy/w142-h200/cover.png" width="142" /></a></div><span style="font-size: small;"><b><a href="http://www.aasmr.org/sisd/Vol.1/Vol.1.1.6.pdf" target="_blank">Medicine Shortages in Cyprus: Perceptions on Causes and Ways of Supply Chain Management</a></b><br /> </span></div><div dir="ltr" style="text-align: left;" trbidi="on"><span style="font-size: small;">Eleni Georgiadou and Panagiotis Petrou<br />European University Cyprus, School of Sciences, Department of Health Sciences, Nicosia, Cyprus<br /><br />Journal of Service, Innovation and Sustainable Development<br />Vol. 1 (2020) No. 1&2, pp. 87-106<br />DOI:10.33168/SISD.2020.0106</span><br /></div><div dir="ltr" style="text-align: left;" trbidi="on"><span style="font-size: small;"><br /></span></div><div dir="ltr" style="text-align: left;" trbidi="on"><span face="arial, tahoma, helvetica, freesans, sans-serif" style="background-color: white; color: #5d5d5d; font-size: 13.2px;"><span face="arial, sans-serif" style="color: #222222; font-size: 12.8px;"><span style="font-size: small;"> </span></span></span></div><div dir="ltr" style="text-align: left;" trbidi="on"><span face="arial, tahoma, helvetica, freesans, sans-serif" style="background-color: white; color: #5d5d5d; font-size: 13.2px;"><span face="arial, sans-serif" style="color: #222222; font-size: 12.8px;"><span style="font-size: small;">To view the online publication, please click <a href="http://www.aasmr.org/sisd/Vol.1/Vol.1.1.6.pdf" target="_blank"><b>here</b></a>: <b><a href="http://www.aasmr.org/sisd/Vol.1/Vol.1.1.6.pdf" target="_blank">http://www.aasmr.org/sisd/Vol.1/Vol.1.1.6.pdf </a></b></span><br /></span></span></div><div dir="ltr" style="text-align: left;" trbidi="on"> </div><div dir="ltr" style="text-align: left;" trbidi="on"> </div><div dir="ltr" style="text-align: left;" trbidi="on"> </div><div dir="ltr" style="text-align: left;" trbidi="on">###</div><div dir="ltr" style="text-align: left;" trbidi="on"></div><div dir="ltr" style="text-align: left;" trbidi="on"></div><div dir="ltr" style="text-align: left;" trbidi="on"><br /><div class="separator" style="clear: both;"><a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhJ5dAEq4r16oad9ZnhexB-yU2_UX6YS2kikg2_WbqP1Z_ER0AkX6AiRgwHZOHayE9-5GdWf2W_14mgzc9l_FV4mzxuEYQbxSg1s0S36BRnvtlC7Damo6REghK5CFFVgxlxOdvV14JdY1Nx/s368/FrontiersInMedicine.jpg" style="display: block; padding: 1em 0px;"><img border="0" data-original-height="166" data-original-width="368" height="90" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhJ5dAEq4r16oad9ZnhexB-yU2_UX6YS2kikg2_WbqP1Z_ER0AkX6AiRgwHZOHayE9-5GdWf2W_14mgzc9l_FV4mzxuEYQbxSg1s0S36BRnvtlC7Damo6REghK5CFFVgxlxOdvV14JdY1Nx/w200-h90/FrontiersInMedicine.jpg" width="200" /><b style="font-size: small;"></b></a><b style="font-size: small;"><a href="https://doi.org/10.3389/fmed.2020.00407" target="_blank">Practical Implications From European Hospital Pharmacists on Prospective Risk Assessment for Medicine Shortages</a></b></div></div><div dir="ltr" style="text-align: left;" trbidi="on"><br /><span face="arial, tahoma, helvetica, freesans, sans-serif" style="background-color: white; color: #5d5d5d; font-size: 13.2px;"><span face="arial, sans-serif" style="color: #222222; font-size: 12.8px;">by Nenad Miljković1*, Eline van Overbeeke, Brian Godman, Milena Kovačević, Alison Anastasi, Tomasz Bochenek, Isabelle Huys and Branislava Miljković</span></span><br /><br /><span face="arial, tahoma, helvetica, freesans, sans-serif" style="background-color: white; color: #5d5d5d; font-size: 13.2px;"><span face="arial, sans-serif" style="color: #222222; font-size: 12.8px;">published in <a href="https://www.frontiersin.org/journals/medicine/sections/regulatory-science" target="_blank">Frontiers in Medicine, Regulatory Science</a>.</span><br style="color: #222222; font-family: arial, sans-serif; font-size: 12.8px;" /><br style="color: #222222; font-family: arial, sans-serif; font-size: 12.8px;" /><span face="arial, sans-serif" style="color: #222222; font-size: 12.8px;">To view the online publication, please click here:</span></span></div><div dir="ltr" style="text-align: left;" trbidi="on"><span face="arial, tahoma, helvetica, freesans, sans-serif" style="background-color: white; color: #5d5d5d; font-size: 13.2px;"><span face="arial, sans-serif" style="color: #222222; font-size: 12.8px;"> <a href="https://doi.org/10.3389/fmed.2020.00407" target="_blank"><b>https://doi.org/10.3389/fmed.2020.00407</b></a></span><br style="color: #222222; font-family: arial, sans-serif; font-size: 12.8px;" /><span face="arial, sans-serif" style="color: #222222; font-size: 12.8px;"> </span></span><br /><span face="arial, tahoma, helvetica, freesans, sans-serif" style="background-color: white; color: #5d5d5d; font-size: 13.2px;"><span face="arial, sans-serif" style="color: #222222; font-size: 12.8px;">This article is an open access publication accessible to readers anywhere in the world. Share the link with your network and track the impact of your research with our Article and Author Impact Metrics. This includes metrics on citations, views and downloads, as well as the social media attention your article receives.</span></span><span face="arial, tahoma, helvetica, freesans, sans-serif" style="background-color: white; color: #5d5d5d; font-size: 13.2px;"></span><br /><span face="arial, tahoma, helvetica, freesans, sans-serif" style="background-color: white; color: #5d5d5d; font-size: 13.2px;"><br /></span><span face="arial, tahoma, helvetica, freesans, sans-serif" style="background-color: white; color: #5d5d5d; font-size: 13.2px;">###</span><br />
<br />
<div class="separator" style="clear: both; text-align: center;">
<a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEh5GpotobULZB-gq18EKTbBRBnF1pr4gqtyaHIUR2EyC0pNtCpikTvJm-F41AS48DUqP9gWBiJqrh3uMwDaEOFxosPR_RpnqsH7VXCsLjrGR5M5bFswfPIDGGdOoL2yWjjYJnwjSY9ZcZBr/s1600/Frontiers+in+Pharmacology.jpg" style="clear: left; float: left; margin-bottom: 1em; margin-right: 1em;" target="_blank"><img alt="https://doi.org/10.3389/fphar.2020.00357" border="0" data-original-height="145" data-original-width="399" height="71" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEh5GpotobULZB-gq18EKTbBRBnF1pr4gqtyaHIUR2EyC0pNtCpikTvJm-F41AS48DUqP9gWBiJqrh3uMwDaEOFxosPR_RpnqsH7VXCsLjrGR5M5bFswfPIDGGdOoL2yWjjYJnwjSY9ZcZBr/s200/Frontiers+in+Pharmacology.jpg" width="200" /></a></div>
<b><div dir="ltr" style="text-align: left;" trbidi="on"><b><br /></b></div><div dir="ltr" style="text-align: left;" trbidi="on"><b><br /></b></div><div dir="ltr" style="text-align: left;" trbidi="on"><b><br /></b></div><div dir="ltr" style="text-align: left;" trbidi="on"><b><br /></b></div><div dir="ltr" style="text-align: left;" trbidi="on"><b><br /></b></div><span style="font-size: small;"><a href="https://www.frontiersin.org/articles/10.3389/fmed.2020.00157/full" target="_blank">Risks in Antibiotic Substitution Following Medicine Shortage: A Health-Care Failure Mode and Effect Analysis of Six European Hospitals</a></span></b><br />
<br />
<span face="arial, tahoma, helvetica, freesans, sans-serif" style="background-color: white; color: #5d5d5d; font-size: 13.2px;"><span face="arial, sans-serif" style="color: #222222; font-size: 12.8px;">by </span></span><span face="arial, tahoma, helvetica, freesans, sans-serif" style="background-color: white; color: #5d5d5d; font-size: 13.2px;"><span face="arial, sans-serif" style="color: #222222; font-size: 12.8px;"><span style="font-family: inherit;"><span style="text-indent: 0cm;">Nenad Miljković*, Brian Godman, Eline van Overbeeke, Milena Kovačević, Karyofyllis Tsiakitzis, Athina Apatsidou, Anna Nikopoulou, Cristina Garcia Yubero, Laura Portillo Horcajada, Gunar Stemer, Darija Kuruc-Poje, Thomas De Rijdt, Tomasz Bochenek, Isabelle Huys and Branislava Miljković</span></span></span></span><br />
<br />
<span face="arial, tahoma, helvetica, freesans, sans-serif" style="background-color: white; color: #5d5d5d; font-size: 13.2px;"><span face="arial, sans-serif" style="color: #222222; font-size: 12.8px;"> published in <a href="https://www.frontiersin.org/articles/10.3389/fphar.2020.00357/full?&utm_source=Email_to_authors_&utm_medium=Email&utm_content=T1_11.5e1_author&utm_campaign=Email_publication&field=&journalName=Frontiers_in_Pharmacology&id=508715" target="_blank">Frontiers in Pharmacology, section Pharmaceutical Medicine and Outcomes Research</a>.</span><br style="color: #222222; font-family: arial, sans-serif; font-size: 12.8px;" /><br style="color: #222222; font-family: arial, sans-serif; font-size: 12.8px;" /><span face="arial, sans-serif" style="color: #222222; font-size: 12.8px;">To view the online publication, please click here:</span></span></div><div dir="ltr" style="text-align: left;" trbidi="on"><span face="arial, tahoma, helvetica, freesans, sans-serif" style="background-color: white; color: #5d5d5d; font-size: 13.2px;"><span face="arial, sans-serif" style="color: #222222; font-size: 12.8px;"> <b><a href="https://www.frontiersin.org/articles/10.3389/fmed.2020.00157/full" target="_blank">https://www.frontiersin.org/articles/10.3389/fmed.2020.00157/full</a> </b></span><br style="color: #222222; font-family: arial, sans-serif; font-size: 12.8px;" /><span face="arial, sans-serif" style="color: #222222; font-size: 12.8px;"> </span></span><br />
<span face="arial, tahoma, helvetica, freesans, sans-serif" style="background-color: white; color: #5d5d5d; font-size: 13.2px;"><span face="arial, sans-serif" style="color: #222222; font-size: 12.8px;">This article is an open access publication accessible to readers anywhere in the world. Share the link with your network and track the impact of your research with our Article and Author Impact Metrics. This includes metrics on citations, views and downloads, as well as the social media attention your article receives.</span></span><span face="arial, tahoma, helvetica, freesans, sans-serif" style="background-color: white; color: #5d5d5d; font-size: 13.2px;"></span><br />
<span face="arial, tahoma, helvetica, freesans, sans-serif" style="background-color: white; color: #5d5d5d; font-size: 13.2px;"><br /></span><span face="arial, tahoma, helvetica, freesans, sans-serif" style="background-color: white; color: #5d5d5d; font-size: 13.2px;">###</span><br />
<br />
<span face="arial, tahoma, helvetica, freesans, sans-serif" style="background-color: white; color: #5d5d5d; font-size: 13.2px;"></span>
<br />
<div class="separator" style="clear: both; text-align: center;">
<a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEh5GpotobULZB-gq18EKTbBRBnF1pr4gqtyaHIUR2EyC0pNtCpikTvJm-F41AS48DUqP9gWBiJqrh3uMwDaEOFxosPR_RpnqsH7VXCsLjrGR5M5bFswfPIDGGdOoL2yWjjYJnwjSY9ZcZBr/s1600/Frontiers+in+Pharmacology.jpg" style="clear: left; float: left; margin-bottom: 1em; margin-right: 1em;" target="_blank"><img alt="https://doi.org/10.3389/fphar.2020.00357" border="0" data-original-height="145" data-original-width="399" height="71" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEh5GpotobULZB-gq18EKTbBRBnF1pr4gqtyaHIUR2EyC0pNtCpikTvJm-F41AS48DUqP9gWBiJqrh3uMwDaEOFxosPR_RpnqsH7VXCsLjrGR5M5bFswfPIDGGdOoL2yWjjYJnwjSY9ZcZBr/s200/Frontiers+in+Pharmacology.jpg" width="200" /></a></div>
<b><div dir="ltr" style="text-align: left;" trbidi="on"><b><br /></b></div><div dir="ltr" style="text-align: left;" trbidi="on"><b><br /></b></div><div dir="ltr" style="text-align: left;" trbidi="on"><b><br /></b></div><div dir="ltr" style="text-align: left;" trbidi="on"><b><br /></b></div><div dir="ltr" style="text-align: left;" trbidi="on"><b><br /></b></div><span style="font-size: small;"><a href="https://www.frontiersin.org/articles/10.3389/fphar.2020.00357/full?&utm_source=Email_to_authors_&utm_medium=Email&utm_content=T1_11.5e1_author&utm_campaign=Email_publication&field=&journalName=Frontiers_in_Pharmacology&id=508715" target="_blank">Prospective Risk Assessment of Medicine Shortages in Europe and Israel: Findings and Implications</a></span></b><br />
<br />
<span face="arial, tahoma, helvetica, freesans, sans-serif" style="background-color: white; color: #5d5d5d; font-size: 13.2px;"><span face="arial, sans-serif" style="color: #222222; font-size: 12.8px;">by </span></span><span face="arial, tahoma, helvetica, freesans, sans-serif" style="background-color: white; color: #5d5d5d; font-size: 13.2px;"><span face="arial, sans-serif" style="color: #222222; font-size: 12.8px;"><span style="font-family: inherit;"><span style="text-indent: 0cm;">Nenad
Miljković, Brian Godman, Milena Kovačević, Piera Polidori, Leonidas
Tzimis, Torsten Hoppe-Tichy, Marika Saar, Ioan Antofie, Laszlo Horvath,
Thomas De Rijdt, Róbert György Vida, Elena Kkolou, David Preece, Biljana
Tubić, Joan Peppard, Alicia Martinez, Cristina Garcia Yubero, Ratiba
Haddad, Dragana Rajinac, Pavle Zelić, Helena Jenzer, Franci Tartar,
Gunda Gitler, Martina Jeske, Michal Davidescu, Guillaume Beraud, Darija
Kuruc-Poje, Kristine Sakstrup Haag, Hanne Fischer, Inese Sviestina,
Gordana Ljubojević, Anne Markestad, Vesna Vujić-Aleksić, Lana Nežić,
Anica Crkvenčić, Johanna Linnolahti, Bogdan Ašanin, Nataša
Duborija-Kovačević, Tomasz Bochenek, Isabelle Huys and Branislava
Miljković</span></span>,</span></span><br />
<br />
<span face="arial, tahoma, helvetica, freesans, sans-serif" style="background-color: white; color: #5d5d5d; font-size: 13.2px;"><span face="arial, sans-serif" style="color: #222222; font-size: 12.8px;"> published in <a href="https://www.frontiersin.org/articles/10.3389/fphar.2020.00357/full?&utm_source=Email_to_authors_&utm_medium=Email&utm_content=T1_11.5e1_author&utm_campaign=Email_publication&field=&journalName=Frontiers_in_Pharmacology&id=508715" target="_blank">Frontiers in Pharmacology, section Pharmaceutical Medicine and Outcomes Research</a>.</span><br style="color: #222222; font-family: arial, sans-serif; font-size: 12.8px;" /><br style="color: #222222; font-family: arial, sans-serif; font-size: 12.8px;" /><span face="arial, sans-serif" style="color: #222222; font-size: 12.8px;">To view the online publication, please click here:</span></span></div><div dir="ltr" style="text-align: left;" trbidi="on"><span face="arial, tahoma, helvetica, freesans, sans-serif" style="background-color: white; color: #5d5d5d; font-size: 13.2px;"><span face="arial, sans-serif" style="color: #222222; font-size: 12.8px;"><b><a href="https://doi.org/10.3389/fphar.2020.00357" target="_blank">https://doi.org/10.3389/fphar.2020.00357</a> </b></span><br style="color: #222222; font-family: arial, sans-serif; font-size: 12.8px;" /><span face="arial, sans-serif" style="color: #222222; font-size: 12.8px;"> </span></span><br />
<span face="arial, tahoma, helvetica, freesans, sans-serif" style="background-color: white; color: #5d5d5d; font-size: 13.2px;"><span face="arial, sans-serif" style="color: #222222; font-size: 12.8px;">This
article is an open access publication accessible to readers anywhere in
the world. Share the link with your network and track the impact of
your research with our Article and Author Impact Metrics. This includes
metrics on citations, views and downloads, as well as the social media
attention your article receives.</span></span>
<span face="arial, tahoma, helvetica, freesans, sans-serif" style="background-color: white; color: #5d5d5d; font-size: 13.2px;"></span><br />
<span face="arial, tahoma, helvetica, freesans, sans-serif" style="background-color: white; color: #5d5d5d; font-size: 13.2px;"><br /></span>
<span face="arial, tahoma, helvetica, freesans, sans-serif" style="background-color: white; color: #5d5d5d; font-size: 13.2px;">###</span><br />
<span face="arial, tahoma, helvetica, freesans, sans-serif" style="background-color: white; color: #5d5d5d; font-size: 13.2px;"><b><br /></b></span>
<span face="arial, tahoma, helvetica, freesans, sans-serif" style="color: blue;"><span style="font-size: 13.2px;"><b><a href="https://doi.org/10.1016/j.ijpharm.2020.119171" target="_blank">New regulatory strategies to manage medicines shortages in Europe</a></b></span></span><br />
<span face="arial, tahoma, helvetica, freesans, sans-serif" style="color: #5d5d5d;"><span style="font-size: 13.2px;"><br /></span></span>
<span face="arial, tahoma, helvetica, freesans, sans-serif" style="color: #5d5d5d;"><span style="font-size: 13.2px;">Umberto M. Musazzi, Domenico Di Giorgio, Paola Minghetti</span></span><br />
<br />
<div class="separator" style="clear: both; text-align: center;">
<a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEg8JPMtA-at4aD3mLdz-vy686UFFuKEIW7Bor5nANVaDgIF4RJjszU9IaC49ZwRs0U0N6ipujVWBhH6-VIxlcYBOO1DnSg-bx8DorhhIKmkPKfp1lJj0bblChl9pGy6LFiGD-2Qj79QAmlT/s1600/Journal.gif" style="clear: left; float: left; margin-bottom: 1em; margin-right: 1em;"><img border="0" data-original-height="150" data-original-width="113" height="200" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEg8JPMtA-at4aD3mLdz-vy686UFFuKEIW7Bor5nANVaDgIF4RJjszU9IaC49ZwRs0U0N6ipujVWBhH6-VIxlcYBOO1DnSg-bx8DorhhIKmkPKfp1lJj0bblChl9pGy6LFiGD-2Qj79QAmlT/s200/Journal.gif" width="150" /></a></div>
<br />
<span face="arial, tahoma, helvetica, freesans, sans-serif" style="color: #5d5d5d;"><span style="font-size: 13.2px;"><br /></span></span>
<span face="arial, tahoma, helvetica, freesans, sans-serif" style="color: #5d5d5d;"><span style="font-size: 13.2px;"><b>International Journal of Pharmaceutics</b></span></span><br />
<span face="arial, tahoma, helvetica, freesans, sans-serif" style="color: #5d5d5d;"><span style="font-size: 13.2px;">Volume 579, 15 April 2020, 119171</span></span><br />
<span face="arial, tahoma, helvetica, freesans, sans-serif" style="color: #5d5d5d;"><span style="font-size: 13.2px;"><br /></span></span>
<span face="arial, sans-serif" style="background-color: white; color: #222222; font-size: 12.8px;"><br /></span>
<span face="arial, sans-serif" style="background-color: white; color: #222222; font-size: 12.8px;"><br /></span>
<span face="arial, sans-serif" style="background-color: white; color: #222222; font-size: 12.8px;">To view / download the publication, please click here:</span><br />
<span face="arial, tahoma, helvetica, freesans, sans-serif" style="color: #5d5d5d;"><span style="font-size: 13.2px;"><br /></span></span>
<span style="font-size: 13.2px;"><span face="arial, tahoma, helvetica, freesans, sans-serif" style="background-color: white; color: #5d5d5d;"></span></span><br />
<span face="arial, tahoma, helvetica, freesans, sans-serif" style="color: #5d5d5d;"><span style="font-size: 13.2px;"><a href="https://doi.org/10.1016/j.ijpharm.2020.119171" target="_blank"><b>https://doi.org/10.1016/j.ijpharm.2020.119171</b></a></span></span><br />
<span face="arial, tahoma, helvetica, freesans, sans-serif" style="color: #5d5d5d;"><span style="font-size: 13.2px;"><br /></span></span>
<span face="arial, tahoma, helvetica, freesans, sans-serif" style="color: #5d5d5d;"><span style="font-size: 13.2px;"><br /></span></span>
<span face="arial, tahoma, helvetica, freesans, sans-serif" style="color: #5d5d5d;"><span style="font-size: 13.2px;"><br /></span></span>
<span face="arial, tahoma, helvetica, freesans, sans-serif" style="color: #5d5d5d;"><span style="font-size: 13.2px;"><br /></span></span>
<br />
<span face="arial, tahoma, helvetica, freesans, sans-serif" style="color: #5d5d5d;"><span style="font-size: 13.2px;"><br /></span></span>
<span face="arial, tahoma, helvetica, freesans, sans-serif" style="color: #5d5d5d;"><span style="font-size: 13.2px;">###</span></span><br />
<span face="arial, tahoma, helvetica, freesans, sans-serif" style="background-color: white; color: #5d5d5d; font-size: 13.2px;"><br /></span>
<span face="arial, tahoma, helvetica, freesans, sans-serif" style="color: #5d5d5d;"><span style="font-size: 13.2px;"><a href="https://www.springer.com/gp/book/9783030153977" target="_blank"><b>Pharmaceutical Supply Chains - Medicines Shortages</b></a></span></span><br />
<span face="arial, tahoma, helvetica, freesans, sans-serif" style="color: #5d5d5d;"><span style="font-size: 13.2px;"><br /></span></span>
<span face="arial, tahoma, helvetica, freesans, sans-serif" style="color: #5d5d5d;"><span style="font-size: 13.2px;">Editors: Barbosa-Povoa, Ana Paula, Jenzer, Helena, de Miranda, João Luís (Eds.)</span></span><br />
<span face="arial, tahoma, helvetica, freesans, sans-serif" style="color: #5d5d5d;"><span style="font-size: 13.2px;"><br /></span></span>
<br />
<div class="separator" style="clear: both; text-align: center;">
<span face="arial, tahoma, helvetica, freesans, sans-serif" style="clear: left; color: #5d5d5d; float: left; margin-bottom: 1em; margin-right: 1em;"><img border="0" data-original-height="231" data-original-width="153" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjdLoV-JYRR1qgD31gNfk6Fh1KE0vTfW6zSESmhlXmzdMBresufXH814ExG55laVm90UL2mH3JEkQHPJcqO53XcJJ-Rsd_zSG6DfxXW7CNncAB0641Vd493NU6IyGNoakqoFYph7ke9E633/s1600/Cover.jpg" /></span></div>
<br />
<div style="text-align: left;">
<span face="arial, tahoma, helvetica, freesans, sans-serif" style="color: #5d5d5d; font-size: 13.2px;">*Provides pharmaceutical case studies</span><br />
<span face="arial, tahoma, helvetica, freesans, sans-serif" style="color: #5d5d5d; font-size: 13.2px;">*Covers uncertainty and risk aspects of supply chain management</span><br />
<span face="arial, tahoma, helvetica, freesans, sans-serif" style="color: #5d5d5d; font-size: 13.2px;">*Carefully combines the scientific level with a pedagogical approach</span><br />
<span face="arial, tahoma, helvetica, freesans, sans-serif" style="color: #5d5d5d; font-size: 13.2px;">*Written by experts in the field </span></div>
<div style="text-align: left;">
<span face="arial, tahoma, helvetica, freesans, sans-serif" style="color: #5d5d5d; font-size: 13.2px;"><br /></span></div>
<span face="arial, tahoma, helvetica, freesans, sans-serif" style="color: #5d5d5d;"><span style="font-size: 13.2px;"> </span></span><span face="arial, tahoma, helvetica, freesans, sans-serif" style="color: #5d5d5d; font-size: 13.2px;">This book provides an insight of relevant case studies and updated practices in “<b>PharmaceuticalSupply Chains</b>” (PharmSC) while addressing the most relevant topics within the <b><a href="http://www.medicinesshortages.eu/" target="_blank">COST Action “Medicines Shortages” (CA15105)</a></b>.</span><br />
<span face="arial, tahoma, helvetica, freesans, sans-serif" style="color: #5d5d5d;"><span style="font-size: 13.2px;"><br /></span></span>
<span face="arial, tahoma, helvetica, freesans, sans-serif" style="color: #5d5d5d;"><span style="font-size: 13.2px;">The volume focuses on the most recent developments in the design, planning and scheduling ofPharmSC, broadening from the suppliers’ selection to the impact on patients and healthcaresystems, addressing uncertainty and risk mitigation, and computational issues. It is directed at MSc/PhD students and young researchers (Post-Docs) in Pharmaceutics/Pharmaceutical sciences, Engineering fields, Economics/Management, as well as pharmaceutical decision makers, managers, and practitioners, and advanced readers demanding a fresh approach to decision making for PharmSC.</span></span><br />
<span face="arial, tahoma, helvetica, freesans, sans-serif" style="color: #5d5d5d;"><span style="font-size: 13.2px;"><br /></span></span>
<span style="font-size: 13.2px;"><span face="arial, tahoma, helvetica, freesans, sans-serif" style="background-color: white; color: #5d5d5d;"></span></span><br />
<span face="arial, tahoma, helvetica, freesans, sans-serif" style="color: #5d5d5d;"><span style="font-size: 13.2px;">The contributed chapters are associated with the homonymous COST Training Schools (TS), and the book creates a better understanding of the Action “Medicines Shortages” challenges and opportunities.</span></span><br />
<span face="arial, tahoma, helvetica, freesans, sans-serif" style="color: #5d5d5d;"><span style="font-size: 13.2px;"><br /></span></span>
<br />
<div style="text-align: left;">
<span style="font-family: inherit;"><span style="color: #5d5d5d;">Springer: </span><a href="https://www.springer.com/gp/book/9783030153977" target="_blank"><b>https://www.springer.com/gp/book/9783030153977</b></a></span></div>
<div style="text-align: left;">
<span style="font-family: inherit;">Springer link: <b><a href="https://link.springer.com/book/10.1007%2F978-3-030-15398-4" target="_blank">https://link.springer.com/book/10.1007%2F978-3-030-15398-4</a> </b></span></div>
<span face="arial, tahoma, helvetica, freesans, sans-serif" style="background-color: white; color: #5d5d5d; font-size: 13.2px;"><br /></span>
<span face="arial, tahoma, helvetica, freesans, sans-serif" style="background-color: white; color: #5d5d5d; font-size: 13.2px;">###</span><br />
<span face="arial, tahoma, helvetica, freesans, sans-serif" style="background-color: white; color: #5d5d5d; font-size: 13.2px;"><br /></span>
<br />
<div class="separator" style="clear: both; text-align: center;">
<a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEh5GpotobULZB-gq18EKTbBRBnF1pr4gqtyaHIUR2EyC0pNtCpikTvJm-F41AS48DUqP9gWBiJqrh3uMwDaEOFxosPR_RpnqsH7VXCsLjrGR5M5bFswfPIDGGdOoL2yWjjYJnwjSY9ZcZBr/s1600/Frontiers+in+Pharmacology.jpg" style="clear: left; float: left; margin-bottom: 1em; margin-right: 1em;"><img border="0" data-original-height="145" data-original-width="399" height="72" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEh5GpotobULZB-gq18EKTbBRBnF1pr4gqtyaHIUR2EyC0pNtCpikTvJm-F41AS48DUqP9gWBiJqrh3uMwDaEOFxosPR_RpnqsH7VXCsLjrGR5M5bFswfPIDGGdOoL2yWjjYJnwjSY9ZcZBr/s200/Frontiers+in+Pharmacology.jpg" width="200" /></a></div>
<span face="arial, tahoma, helvetica, freesans, sans-serif" style="background-color: white; color: #5d5d5d; font-size: 13.2px;"><br /></span><span face="arial, tahoma, helvetica, freesans, sans-serif" style="background-color: white; font-size: 13.2px;"><span face="arial, sans-serif" style="font-size: 12.8px;"><b><a href="http://journal.frontiersin.org/article/10.3389/fphar.2017.00942/full?&utm_source=Email_to_authors_&utm_medium=Email&utm_content=T1_11.5e1_author&utm_campaign=Email_publication&field=&journalName=Frontiers_in_Pharmacology&id=323253" target="_blank"><span style="color: blue;">Systemic Measures and Legislative and Organizational Frameworks Aimed at Preventing or Mitigating Drug Shortages in 28 European and Western Asian Countries</span></a></b><span style="color: #5d5d5d;">, </span></span></span><br />
<br />
<span face="arial, tahoma, helvetica, freesans, sans-serif" style="background-color: white; color: #5d5d5d; font-size: 13.2px;"><span face="arial, sans-serif" style="color: #222222; font-size: 12.8px;">by Tomasz Bochenek, Vafa Abilova, Ali Alkan, Bogdan Asanin, Iñigo de Miguel Beriain, Zeljka Besovic, Patricia Vella Bonanno, Anna Bucsics, Michal Davidescu, Elfi De Weerdt, Natasa Duborija-Kovacevic, Jurij Fürst, Mina Gaga, Elma Gailīte, Jolanta Gulbinovič, Emre Umut Gürpınar, Balázs Hankó, Vincent Hargaden, Tor Arne Hotvedt, Iris Hoxha, Isabelle Huys, Andras Inotai, Arianit Jakupi, Helena Jenzer, Roberta Joppi, Ott Laius, Marie-Camille Lenormand, Despina Makridaki, Admir Malaj, Kertu Margus, Vanda Marković-Peković, Nenad Miljković, João Luís de Miranda, Stanislav Primožič, Dragana Rajinac, David G. Schwartz, Robin Šebesta, Steven Simoens, Juraj Slaby, Ljiljana Sović-Brkičić, Tomas Tesar, Leonidas Tzimis, Ewa Warmińska, Brian Godman, published in Frontiers in Pharmacology, section Pharmaceutical Medicine and Outcomes Research.</span><br style="color: #222222; font-family: arial, sans-serif; font-size: 12.8px;" /><br style="color: #222222; font-family: arial, sans-serif; font-size: 12.8px;" /><span face="arial, sans-serif" style="color: #222222; font-size: 12.8px;">To view the online publication, please click here:</span><br style="color: #222222; font-family: arial, sans-serif; font-size: 12.8px;" /><br style="color: #222222; font-family: arial, sans-serif; font-size: 12.8px;" /><a data-saferedirecturl="https://www.google.com/url?hl=en&q=http://journal.frontiersin.org/article/10.3389/fphar.2017.00942/full?%26utm_source%3DEmail_to_authors_%26utm_medium%3DEmail%26utm_content%3DT1_11.5e1_author%26utm_campaign%3DEmail_publication%26field%3D%26journalName%3DFrontiers_in_Pharmacology%26id%3D323253&source=gmail&ust=1516535183736000&usg=AFQjCNEZEBLmBbCIv-S-q4w6ZF6utHK8GQ" href="http://journal.frontiersin.org/article/10.3389/fphar.2017.00942/full?&utm_source=Email_to_authors_&utm_medium=Email&utm_content=T1_11.5e1_author&utm_campaign=Email_publication&field=&journalName=Frontiers_in_Pharmacology&id=323253" rel="noreferrer" style="color: #1155cc; font-family: arial, sans-serif; font-size: 12.8px;" target="_blank">http://journal.frontiersin.org<wbr></wbr>/article/10.3389/fphar.2017.<wbr></wbr>00942/full?&utm_source=Email_<wbr></wbr>to_authors_&utm_medium=Email&<wbr></wbr>utm_content=T1_11.5e1_author&<wbr></wbr>utm_campaign=Email_publication<wbr></wbr>&field=&journalName=Frontiers_<wbr></wbr>in_Pharmacology&id=323253</a><br style="color: #222222; font-family: arial, sans-serif; font-size: 12.8px;" /><br style="color: #222222; font-family: arial, sans-serif; font-size: 12.8px;" /><span face="arial, sans-serif" style="color: #222222; font-size: 12.8px;">This article is an open access publication accessible to readers anywhere in the world. Share the link with your network and track the impact of your research with our Article and Author Impact Metrics. This includes metrics on citations, views and downloads, as well as the social media attention your article receives.</span></span>
<span face="arial, tahoma, helvetica, freesans, sans-serif" style="background-color: white; color: #5d5d5d; font-size: 13.2px;"><br /></span>
<span face="arial, tahoma, helvetica, freesans, sans-serif" style="background-color: white; color: #5d5d5d; font-size: 13.2px;"><br /></span></div>
Medicines Shortages in Europehttp://www.blogger.com/profile/07362716140541888698noreply@blogger.comtag:blogger.com,1999:blog-5764090054909858273.post-5994076516185843092018-01-20T01:30:00.000+01:002018-11-22T18:30:18.962+01:00Section for MC members<div dir="ltr" style="text-align: left;" trbidi="on">
<br />
<br />
The place where Management Committee members can join the action's forum for discussion:<br />
<br />
<b><a href="https://groups.google.com/forum/#!forum/medicinesshortages" target="_blank"><span style="color: blue;">Google group</span></a></b><br />
<br />
<br />
<br />
The place where the Management Committee members can reach all the documents of the action and they can organize, add and edit.<br />
<br />
<b><a href="https://drive.google.com/drive/folders/1ozPPsm41er-w3g3wj2ylhatSF9o3cI9O?usp=sharing" target="_blank"><span style="color: blue;">Google drive documents</span></a></b><br />
<br />
<br /></div>
Medicines Shortages in Europehttp://www.blogger.com/profile/07362716140541888698noreply@blogger.com